Retrograde Cricopharyngeus Dysfunction

Syndromic MONDO:0100099 Pathograph 14 Show in embeddings browser Neuromuscular Disorder Gastrointestinal Disorder

An upper esophageal sphincter motility disorder characterized by the inability to belch due to reflex-specific failure of the cricopharyngeus muscle to relax in response to retrograde esophageal gaseous distension, while antegrade swallowing relaxation remains intact. Unvented intraesophageal gas triggers secondary peristalsis and passes distally, producing the cardinal symptom complex of inability to belch (abelchia), socially awkward gurgling noises in the chest and neck, abdominal bloating and distension, retrosternal chest pain, excessive flatulence, nausea, and painful hiccups.

Ask OpenScientist

Ask a research question about Retrograde Cricopharyngeus Dysfunction. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🏷

Classifications

Harrison's Part
GASTROINTESTINAL
👪

Inheritance

2
Sporadic HP:0003745
Roughly 71% to 72% of patients present sporadically without a known family history of inability to belch.
Sporadic
Show evidence (1 reference)
PMID:40411338 SUPPORT Human clinical
"A family history was reported in 28.0% of cases with most patients developing R-CDP symptoms in childhood (55.5%)."
Systematic review indicates that the majority (~72%) of cases occur without a reported family history.
Non-Mendelian Familial Aggregation HP:0001426
Approximately 28% to 29% of patients report affected family members, suggesting a heritable predisposition in a subset of cases; no causative Mendelian gene has been identified, and positive family history predicts lower single-injection botulinum toxin success.
Non-Mendelian inheritance
Show evidence (3 references)
PMID:39883449 SUPPORT Human clinical
"A family history was reported in 18 of 62 cases (29.0%)."
Documents familial clustering in 29.0% of evaluated patients in a prospective clinical cohort.
PMID:39883449 SUPPORT Human clinical
"Family history of R-CPD was a negative predictor of single-BTI success."
Identifies familial R-CPD as clinically distinct in having a higher rate of incomplete response to a single botulinum toxin injection.
PMID:31236539 SUPPORT Human clinical
"What is the familial incidence of R-CPD? Several patients mentioned a family member with the same problem."
Notes familial occurrence in the initial description of R-CPD.
⚙

Pathophysiology

5
Failure of Upper Esophageal Sphincter Relaxation
Mechanism confidence: Established
The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.
muscle cell CL:0000187 ⚠ ABNORMAL Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves abnormal muscle cell (CL:0000187). CL:0000187 is a cell type from the Cell Ontology. sensory neuron CL:0000101 ⚠ ABNORMAL Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves abnormal sensory neuron (CL:0000101). CL:0000101 is a cell type from the Cell Ontology.
regulation of muscle contraction GO:0006937 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of muscle contraction (GO:0006937). GO:0006937 is a biological process from the Gene Ontology. skeletal muscle contraction GO:0003009 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal skeletal muscle contraction (GO:0003009). GO:0003009 is a biological process from the Gene Ontology.
upper esophageal sphincter UBERON:0007268 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in upper esophageal sphincter (UBERON:0007268). UBERON:0007268 is an anatomical location from the Uberon multi-species anatomy ontology. cricopharyngeus muscle UBERON:0010928 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cricopharyngeus muscle (UBERON:0010928). UBERON:0010928 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Intraesophageal Gas Trapping Failure of the cricopharyngeus muscle to relax during retrograde gas venting traps air within the esophageal body, equalizing esophageal and gastric pressures and producing low-pressure esophageal distension.
Inability to Belch Absent retrograde upper esophageal sphincter relaxation directly prevents air venting across the cricopharyngeus muscle, resulting in complete inability to belch.
Show evidence (4 references)
PMID:35122356 SUPPORT Other
"prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention"
The Kahrilas 2022 review establishes that UES relaxation failure during retrograde gas events is the core pathophysiological mechanism.
PMID:38587015 SUPPORT Human clinical
"RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
The Yousef 2024 case-control study demonstrated physiological abnormalities in UES function in R-CPD patients.
PMID:41506952 SUPPORT Human clinical
"high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."
The Dealino 2026 cases document absent UES relaxation during attempted belching.
+ 1 more reference
Elevated Upper Esophageal Sphincter Basal Pressure
Mechanism confidence: Provisional
Preoperative high-resolution manometry case-control data show that R-CPD is associated with a significantly longer upper esophageal sphincter high-pressure zone and elevated resting basal pressure compared to asymptomatic controls; whether this resting hypertonicity directly raises the mechanical threshold for retrograde opening or co-occurs with a central defect of the belch reflex remains unresolved.
muscle cell CL:0000187 ⚠ ABNORMAL Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves abnormal muscle cell (CL:0000187). CL:0000187 is a cell type from the Cell Ontology.
muscle contraction GO:0006936 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased muscle contraction (GO:0006936). GO:0006936 is a biological process from the Gene Ontology.
upper esophageal sphincter UBERON:0007268 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in upper esophageal sphincter (UBERON:0007268). UBERON:0007268 is an anatomical location from the Uberon multi-species anatomy ontology. cricopharyngeus muscle UBERON:0010928 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cricopharyngeus muscle (UBERON:0010928). UBERON:0010928 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Failure of Upper Esophageal Sphincter Relaxation Elevated resting cricopharyngeus pressure and increased sphincter length are manometrically associated with R-CPD and may increase the mechanical threshold against retrograde upper esophageal sphincter opening, although a direct causal contribution beyond the reflex-specific relaxation defect has not been established.
Show evidence (2 references)
PMID:38587015 SUPPORT Human clinical
"RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
The case-control study quantified significantly greater UES length (4.5 vs 3.7 cm) and higher UES basal pressures (91.9 vs 49.7 mm Hg) in R-CPD patients relative to controls.
PMID:41506952 SUPPORT Human clinical
"high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."
Elevated resting UES pressure was observed in both cases in the 2026 report.
Intraesophageal Gas Trapping
Mechanism confidence: Established
When gastric gas vents across the lower esophageal sphincter into the esophageal body during a transient lower esophageal sphincter relaxation, failure of the upper esophageal sphincter to open traps the air bolus in the esophagus, equalizing esophageal pressure with gastric pressure and causing low-pressure gaseous esophageal distension and dilation.
esophagus UBERON:0001043 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in esophagus (UBERON:0001043). UBERON:0001043 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Secondary Peristalsis Gaseous distension and pressure equalization within the esophageal body from unvented air trigger repetitive secondary peristaltic contractions to sweep the trapped gas bolus distally.
Chest Pain Pressurized gaseous distension of the esophagus produces sharp retrosternal chest discomfort.
Abdominal Distention Unvented gas retained in the upper gastrointestinal tract and returned distally into the stomach and intestines causes progressive abdominal bloating and distension.
Excessive Flatulence Unvented upper gastrointestinal gas that cannot be expelled orally transits the intestinal tract and is expelled as excessive flatus.
Nausea Postprandial gaseous distension of the esophagus and stomach triggers nausea.
Hiccups Hiccups occur as part of the associated R-CPD symptom complex inferred to result downstream of unvented gaseous esophageal and gastric distension, although the intermediate reflex pathway is not directly characterized in the R-CPD literature.
Show evidence (3 references)
PMID:35122356 SUPPORT Other
"Indeed, prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention."
Establishes that failure of UES relaxation after gastric gas venting results in low-pressure gaseous esophageal distension.
PMID:31236539 SUPPORT Human clinical
"Patulous esophagus. The cricopharyngeus muscle (CPM) is being retracted posteriorly with a suction cannula (under arrow). As an unvalidated observation, the esophagus seen beyond the CPM typically appears to be abnormally open and even dilated."
Endoscopic observation in the original R-CPD cohort notes an abnormally open and dilated esophageal lumen distal to the cricopharyngeus muscle consistent with chronic gas trapping.
PMID:31236539 SUPPORT Human clinical
"Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
Links trapped gas and resulting distension of the esophagus, stomach, and intestines to the downstream clinical syndrome.
Secondary Peristalsis
Mechanism confidence: Established
Repetitive secondary peristaltic contractions of the esophageal body are triggered in response to intraesophageal gaseous distension and elevated esophageal pressure when the upper esophageal sphincter fails to relax during attempted belching, sweeping the trapped air bolus distally back toward the stomach.
peristalsis GO:0030432 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased peristalsis (GO:0030432). GO:0030432 is a biological process from the Gene Ontology.
esophagus UBERON:0001043 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in esophagus (UBERON:0001043). UBERON:0001043 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Gurgling Sounds Oscillating intraesophageal gas propelled by secondary peristalsis against a closed upper esophageal sphincter generates audible retrosternal and cervical gurgling noises.
Show evidence (2 references)
PMID:38767031 SUPPORT Human clinical
"We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."
Demonstrates on provocative high-resolution manometry that secondary peristalsis occurs when the patient experiences the need to belch against an unrelaxed UES.
PMID:38767031 SUPPORT Human clinical
"We encourage the use of HRM, looking for an increase in esophageal pressure to the level of gastric pressure, failure of UES relaxation with consequently no venting of air across the UES, and secondary peristalsis."
Defines secondary peristalsis following esophageal pressure equalization and absent UES relaxation as part of the characteristic manometric triad of R-CPD.
Ineffective Esophageal Motility
Mechanism confidence: Provisional
Preoperative high-resolution impedance manometry case-control data show a high prevalence of ineffective esophageal motility in R-CPD, characterized by elevated rates of ineffective swallows and incomplete bolus clearance; whether this hypomotility is a primary contributor to impaired gas clearance or a secondary consequence of chronic gaseous esophageal distension and dilation remains unresolved.
peristalsis GO:0030432 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased peristalsis (GO:0030432). GO:0030432 is a biological process from the Gene Ontology.
esophagus UBERON:0001043 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in esophagus (UBERON:0001043). UBERON:0001043 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Intraesophageal Gas Trapping Impaired esophageal body clearance and high rates of ineffective swallows are manometrically associated with R-CPD and may contribute to intraesophageal gas and bolus retention, although causality could also run in the reverse direction from chronic esophageal distension.
Show evidence (2 references)
PMID:38587015 SUPPORT Human clinical
"RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
Establishes ineffective esophageal motility as a key manometric abnormality associated with R-CPD.
PMID:38587015 SUPPORT Human clinical
"Patients with RCPD demonstrated higher rates of ineffective swallows [70.0% (31.6%) vs 15.4% (21.6%), P < .001] and incomplete bolus clearance [81% (22.0%) vs 21.8% (30.0%), P < .001]."
Provides case-control quantitative evidence of impaired peristaltic swallows and bolus clearance in R-CPD patients.
⬡

Pathograph

Use Group by to collapse related nodes into one box. Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Retrograde Cricopharyngeus Dysfunction Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

7
Digestive 5
Inability to Belch VERY_FREQUENT Abnormality of the digestive system HP:0025031 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Inability to belch, annotated with Abnormality of the digestive system (HP:0025031). HP:0025031 is a phenotype from the Human Phenotype Ontology.
Coarse binding: no hpo term
Ontology gap: HPO has Belching (HP:0025262) and Aerophagia (HP:0031594) under Abnormality of digestive system physiology (HP:0025032), but no term for inability to belch (abelchia / retrograde eructation failure).
Show evidence (5 references)
PMID:31236539 SUPPORT Human clinical
"To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"
This landmark paper defined R-CPD and established inability to belch as the cardinal feature.
PMID:37621856 SUPPORT Human clinical
"A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
The Pavesi 2023 case report reiterates inability to burp as the defining symptom of R-CPD.
PMID:38767031 SUPPORT Human clinical
"The incapacity to belch is the hallmark of the disease."
The Jiménez-Castillo 2025 series states the hallmark symptom is inability to belch.
+ 2 more references
Abdominal Distention VERY_FREQUENT HP:0003270 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abdominal distention (HP:0003270). HP:0003270 is a phenotype from the Human Phenotype Ontology.
Show evidence (4 references)
PMID:35122356 SUPPORT Other
"The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
Bloating (abdominal distention) is described as part of the core symptom complex of R-CPD.
PMID:37621856 SUPPORT Human clinical
"A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
The Pavesi 2023 case report lists abdominal bloating as a key symptom.
PMID:38115814 SUPPORT Human clinical
"99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
Community survey data show abdominal bloating affects nearly all respondents with R-CPD.
+ 1 more reference
Nausea OCCASIONAL HP:0002018 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nausea (HP:0002018). HP:0002018 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:35122356 SUPPORT Other
"The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
Nausea is described as part of the symptom complex associated with R-CPD.
PMID:31236539 SUPPORT Human clinical
"Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
Notes postprandial nausea accompanying esophageal and gastric gaseous distension.
Gurgling Sounds VERY_FREQUENT Abnormality of the digestive system HP:0025031 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Gurgling sounds in neck and chest, annotated with Abnormality of the digestive system (HP:0025031). HP:0025031 is a phenotype from the Human Phenotype Ontology.
Coarse binding: no hpo term
Ontology gap: HPO has no term for audible esophageal or retrosternal gurgling noises (borborygmi-like sounds in the lower neck and chest due to trapped esophageal gas).
Show evidence (4 references)
PMID:31236539 SUPPORT Human clinical
"To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"
Loud gurgling noises are described as a core feature of R-CPD.
PMID:37621856 SUPPORT Human clinical
"A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
Gurgling noises from the chest and lower neck are highlighted among the presenting symptoms.
PMID:38115814 SUPPORT Human clinical
"99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
Survey responses show gurgling noises are frequent in R-CPD.
+ 1 more reference
Excessive Flatulence VERY_FREQUENT HP:0033589 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Excessive flatulence, annotated with Flatulence (HP:0033589). HP:0033589 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:31236539 SUPPORT Human clinical
"The fourth primary symptom comprising the syndrome of R-CPD was less universal and found in 43 of 51: excessive flatulence."
Identifies excessive flatulence in 43 of 51 (84%) patients in the original R-CPD cohort.
PMID:40411338 SUPPORT Human clinical
"In addition to the cardinal symptom of the inability to belch, associated complaints of bloating and chest pain, gurgling noises, and excessive flatulence were found in 95.7%, 86%, and 80.2% of cases, respectively."
Systematic review of 826 patients reporting excessive flatulence in 80.2% of cases.
PMID:38115814 SUPPORT Human clinical
"99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
Survey of 199 affected adults reporting excessive flatulence in 89% of respondents.
Constitutional 2
Chest Pain VERY_FREQUENT HP:0100749 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Chest pain (HP:0100749). HP:0100749 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:35122356 SUPPORT Other
"The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
Chest pain is identified as a core symptom of retrograde UES dysfunction.
PMID:31236539 SUPPORT Human clinical
"Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
Documents sharp central chest pain as part of the distension-related symptom complex in 49 of 51 patients.
PMID:40411338 SUPPORT Human clinical
"In addition to the cardinal symptom of the inability to belch, associated complaints of bloating and chest pain, gurgling noises, and excessive flatulence were found in 95.7%, 86%, and 80.2% of cases, respectively."
Systematic review confirming high prevalence of chest pain and bloating across 17 studies.
Hiccups OCCASIONAL Recurrent singultus HP:0100247 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Painful hiccups, annotated with Recurrent singultus (HP:0100247). HP:0100247 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:35122356 SUPPORT Other
"The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
Lists hiccups as part of the associated symptom complex of R-CPD.
PMID:37621856 SUPPORT Human clinical
"A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
Highlights painful hiccups among the characteristic symptoms of R-CPD.
💊

Medical Actions

2
Botulinum Toxin Injection
Action: botulinum toxin type A therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is botulinum toxin type A therapy, annotated with Botulinum Toxin Therapy (NCIT:C157775). NCIT:C157775 is a clinical intervention from the NCI Thesaurus. Ontology label: Botulinum Toxin Therapy NCIT:C157775
Agent: botulinum toxin type A CHEBI:3160 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses botulinum toxin type A (CHEBI:3160). CHEBI:3160 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Other
Injection of botulinum toxin type A (typically 50 to 100 units, with efficacy reported down to 10 units) into the cricopharyngeus muscle via operating-room rigid or flexible esophagoscopy or awake in-office electromyography-guided percutaneous/transtracheal approaches. Temporary chemodenervation relaxes the upper esophageal sphincter, serving as both a confirmatory diagnostic test and definitive therapy that frequently leads to durable reflex retraining beyond the pharmacologic half-life of the toxin.
Mechanism Target:
INHIBITS Failure of Upper Esophageal Sphincter Relaxation — Chemodenervation of the cricopharyngeus muscle blocks presynaptic acetylcholine release, lowering sphincter resistance to permit retrograde gas venting and durable central reprogramming of the belch reflex.
Show evidence (1 reference)
PMID:31236539 SUPPORT Human clinical
"All 51 patients achieved ability to belch and relief of associated symptoms, and the majority seem to have "retrained" the ability to belch on a potentially "permanent" basis."
Demonstrates that botulinum toxin injection restores retrograde UES relaxation and induces durable belch retraining.
Target Phenotypes: Inability to belch HP:0025031 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Inability to belch, annotated with Abnormality of the digestive system (HP:0025031). HP:0025031 is a phenotype from the Human Phenotype Ontology. Socially awkward gurgling noises HP:0025031 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Socially awkward gurgling noises, annotated with Abnormality of the digestive system (HP:0025031). HP:0025031 is a phenotype from the Human Phenotype Ontology. Abdominal bloating and distension HP:0003270 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Abdominal bloating and distension, annotated with Abdominal distention (HP:0003270). HP:0003270 is a phenotype from the Human Phenotype Ontology. Chest pain HP:0100749 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Chest pain (HP:0100749). HP:0100749 is a phenotype from the Human Phenotype Ontology. Excessive flatulence HP:0033589 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Excessive flatulence, annotated with Flatulence (HP:0033589). HP:0033589 is a phenotype from the Human Phenotype Ontology.
Effect differs by subgroup:
other Patients with positive family history of R-CPD vs Patients without family history of R-CPD — smaller effect on Single-injection botulinum toxin symptom resolution post hoc subgroup
A positive family history of R-CPD is associated with reduced likelihood of symptom resolution after a single in-office botulinum toxin injection.
Show evidence (1 reference)
PMID:39883449 SUPPORT Human clinical
"Family history of R-CPD was a negative predictor of single-BTI success."
Identifies family history of R-CPD as a negative predictor of single-injection botulinum toxin efficacy.
Show evidence (8 references)
PMID:31236539 SUPPORT Human clinical
"All 51 patients achieved ability to belch and relief of associated symptoms, and the majority seem to have "retrained" the ability to belch on a potentially "permanent" basis."
The Bastian 2019 case series demonstrated 100% success rate with botulinum toxin injection in restoring belching ability.
DOI:10.1177/2473974x20938342 SUPPORT Human clinical
"a case series of 200 patients with retrograde cricopharyngeus dysfunction, 99% experienced relief of the cardinal symptoms and 79.9% experienced lasting relief of their symptoms beyond pharmacologic duration of action after a single injection of botulinum toxin into the cricopharyngeus muscle."
The Hoesli 2020 200-patient follow-up cohort establishes 99% initial relief and 79.9% durable symptom resolution at 6 or more months after a single botulinum toxin injection.
PMID:38587015 SUPPORT Human clinical
"All patients who underwent cricopharyngeal botulinum injections experienced initial improvement of symptoms with 3 patients requiring repeat intervention."
The Yousef 2024 study confirms botulinum toxin as an effective treatment.
+ 5 more references
Endoscopic Cricopharyngeal Myotomy
Action: cricopharyngeal myotomyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cricopharyngeal myotomy, annotated with Surgical Procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Surgery
Surgical or endoscopic division of the cricopharyngeus muscle fibers reserved for patients with refractory R-CPD whose symptoms recur after botulinum toxin injections or who are intolerant of repeated injections.
Mechanism Target:
BYPASSES Failure of Upper Esophageal Sphincter Relaxation — Myotomy permanently divides the cricopharyngeus muscle barrier, allowing retrograde esophageal gas venting in botulinum-refractory cases.
Show evidence (1 reference)
PMID:41506952 SUPPORT Human clinical
"The second case involves a 30-year-old female with refractory symptoms who was effectively managed with endoscopic cricopharyngeal myotomy. She had previously undergone percutaneous botulinum toxin injection that initially provided temporary relief."
Demonstrates effective surgical resolution of refractory R-CPD via endoscopic cricopharyngeal myotomy after temporary response to botulinum toxin.
Target Phenotypes: Inability to belch HP:0025031 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Inability to belch, annotated with Abnormality of the digestive system (HP:0025031). HP:0025031 is a phenotype from the Human Phenotype Ontology.
Show evidence (4 references)
PMID:41506952 SUPPORT Human clinical
"The second case involves a 30-year-old female with refractory symptoms who was effectively managed with endoscopic cricopharyngeal myotomy. She had previously undergone percutaneous botulinum toxin injection that initially provided temporary relief."
Documents successful management of botulinum-refractory R-CPD with endoscopic cricopharyngeal myotomy.
PMID:41506952 SUPPORT Human clinical
"For refractory cases and those intolerant of repeated injections, more extensive surgery, including cricopharyngeal myotomy, may be offered."
Establishes cricopharyngeal myotomy as a salvage surgical option for refractory R-CPD.
DOI:10.1177/2473974x20938342 SUPPORT Human clinical
"Of those who did not maintain the ability, 12 underwent a second injection, 1 patient underwent 3 subsequent injections, and 3 patients underwent partial myotomy."
Documents partial cricopharyngeus myotomy as a salvage intervention among patients whose symptoms recurred after botulinum toxin injection in the 200-patient series.
+ 1 more reference
🔬

Diagnosis

2
Syndromic Clinical Diagnosis and Therapeutic Botulinum Toxin Trial
Primary diagnosis is established clinically from the characteristic symptom tetrad (inability to belch, retrosternal/cervical gurgling noises, abdominal bloating/distension, and excessive flatulence) and definitively validated by symptom resolution following cricopharyngeal botulinum toxin injection.
Show evidence (1 reference)
PMID:31236539 SUPPORT Human clinical
"R-CPD can be diagnosed syndromically, using a symptom complex; clinical diagnosis is validated by relief of symptoms after BT injection; and BT into the CPM is an efficacious treatment, whose benefit appears to often last longer than the pharmacologic duration of action of BT."
Establishes syndromic clinical diagnosis validated by response to cricopharyngeal botulinum toxin injection as the primary diagnostic paradigm for R-CPD.
High-Resolution Impedance Manometry
High-resolution impedance manometry (HRIM) with a provocative carbonated water challenge (e.g., 500 mL) objectively demonstrates increased esophageal pressure equilibrating with gastric pressure, absence of upper esophageal sphincter relaxation with no air venting across the UES, and repetitive secondary peristalsis, alongside elevated basal UES pressure and increased UES length.
high-resolution impedance manometry of the upper esophageal sphincter LOINC:51393-7 Logical Observation Identifiers Names and Codes (LOINC)
LOINC codes esophageal manometry once, as a study whose result is a report, and that single record is what is bound: one match in the full LOINC 2.83 table and one in the Monarch KG, paginated to its stated total, with no Part. Two things it does not capture, recorded so the binding is not read as more than it is. The release has no high-resolution or impedance variant, so the modality this row specifies is not in the code. And it has no code for the provocative carbonated-water challenge that makes the test diagnostic here. The release's one quantitative esophageal pressure code, LOINC:60738-2, is a single intraluminal pressure rather than a manometry study and is not bound. No reference range is bound: the row's finding is failure of relaxation during distension, not a pressure threshold.
Show evidence (4 references)
PMID:35122356 SUPPORT Other
"The field has now further advanced with the publication in this issue of the Journal by Oude Nijhuis et al. of 8 cases of R-UESD demonstrated by high-resolution impedance manometry (HRIM) with a provocative challenge of carbonated water."
HRIM with provocative testing provides objective diagnostic confirmation of R-CPD.
PMID:38587015 SUPPORT Human clinical
"Esophageal high-resolution impedance manometry was completed preoperatively in patients diagnosed with RCPD."
HRIM is used for demonstrating UES abnormalities in R-CPD.
PMID:38767031 SUPPORT Human clinical
"We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."
HRM with belch provocation shows characteristic pressure rise and absent UES relaxation in R-CPD.
+ 1 more reference
📈

Progression

2
Infancy and early childhood onset
Age: Infancy to childhood
Many patients have a lifelong or potentially congenital inability to burp, with parental reports of inability to be burped in infancy accompanied by colic, projectile vomiting, or excessive gas in 29% to 64.2% of cases.
Show evidence (2 references)
PMID:31236539 SUPPORT Human clinical
"At least 15 (29%) had been told they could not be burped in infancy and had colic, projectile vomiting, or “incredible gassiness.”"
Documents infantile onset of inability to burp and associated feeding symptoms in the index cohort.
PMID:39883449 SUPPORT Human clinical
"Sixty-eight patients (64.2%) had potential congenital R-CPD, according to the parents' testimonies."
Prospective series showing nearly two-thirds of patients had parentally reported congenital onset.
Adolescent symptom amplification and adult diagnosis
Age: Adolescence to young adulthood (mean onset 13.6 years; mean diagnosis ~30 years)
While inability to burp is often lifelong, distressing secondary symptoms (bloating, gurgling, chest pain, flatulence) typically intensify during childhood or adolescence (mean age 13.6 years), followed by a prolonged diagnostic delay until young adulthood (mean age ~30 years).
Show evidence (3 references)
PMID:39883449 SUPPORT Human clinical
"Their mean (SD) age at symptom onset was 13.6 (7.7) years, and at diagnosis, 30.4 (6.4) years."
Quantifies mean age of symptomatic onset in early adolescence and diagnostic delay into the fourth decade.
PMID:40411338 SUPPORT Human clinical
"A family history was reported in 28.0% of cases with most patients developing R-CDP symptoms in childhood (55.5%)."
Systematic review confirming that over half of patients develop symptoms in childhood.
PMID:38256547 SUPPORT Other
"Complaints often start during adolescence, and many patients search for a diagnosis for years before obtaining treatment."
Highlights adolescent symptom escalation and multi-year diagnostic delay.
📊

Prevalence

1
Global published clinical cohorts
Cases/families reported in the literature Unknown
True population prevalence has not been established in epidemiological surveys. A 2025 systematic review compiled 826 published cases across 17 studies with balanced sex distribution, though clinical series note substantial underdiagnosis and rapid growth in patient-initiated presentations via online communities.
Show evidence (3 references)
PMID:40411338 SUPPORT Human clinical
"ResultsSeventeen studies met the inclusion criteria (826 patients)."
Quantifies the total published clinical cohort size across 17 studies in the 2025 systematic review.
PMID:40411338 SUPPORT Human clinical
"Conclusion and relevanceR-CPD is a recently-recognized and likely-underdiagnosed condition associated with severe symptoms affecting the quality of life of patients."
Notes that true population prevalence remains underestimated because R-CPD is newly recognized and underdiagnosed.
PMID:38256547 SUPPORT Other
"A recent increase in awareness through patient-led social media discussion boards describing the 'no burp' syndrome is leading to an increasing incidence of presentations, often with patients making a self-diagnosis."
Explains the rising clinical recognition and self-referral pattern driven by patient awareness.
⚖️

Clinical Burden

Moderate
Although non-fatal, R-CPD causes daily physical discomfort (bloating, chest pain) and substantial psychosocial morbidity—including social anxiety, embarrassment over loud gurgling and flatulence, dietary restrictions, work disruption, and relationship strain—compounded by widespread under-recognition among clinicians.
Show evidence (2 references)
PMID:38115814 SUPPORT Human clinical
"Average Likert scores indicated embarrassment (3.4), anxiety/depression (3.1), negative impact on relationships (2.6), and work disruption (2.7) due to R-CPD."
Quantifies the psychosocial, emotional, interpersonal, and occupational burden of R-CPD in a 199-patient survey.
PMID:38256547 SUPPORT Other
"RCPD negatively impacts patients' quality of life and is associated with bloating, gurgling, avoidance of carbonation, self-imposed dietary and lifestyle changes designed to minimize discomfort, and flatulence."
Summarizes quality-of-life impairment and restrictive lifestyle adaptations required to manage daily symptoms.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Retrograde Cricopharyngeus Dysfunction:

Supragastric Belching
Overlapping Features Functional belching disorder characterized by repetitive supradiaphragmatic air influx and frequent belches, rather than an inability to vent esophageal gas.
Distinguishing Features
  • Patients exhibit frequent, often repetitive belching episodes instead of inability to belch.
  • High-resolution manometry with belch provocation in R-CPD demonstrates an increase in esophageal pressure to the level of gastric pressure, failure of UES relaxation with no venting of air across the UES, and secondary peristalsis.
Show evidence (2 references)
PMID:38767031 SUPPORT Human clinical
"The incapacity to belch is the hallmark of the disease."
R-CPD is defined by inability to belch, distinguishing it from conditions like supragastric belching where belching is frequent.
PMID:38767031 SUPPORT Human clinical
"We encourage the use of HRM, looking for an increase in esophageal pressure to the level of gastric pressure, failure of UES relaxation with consequently no venting of air across the UES, and secondary peristalsis."
Establishes the characteristic high-resolution manometry findings of R-CPD during belch provocation.
Antegrade Cricopharyngeus Dysfunction
Overlapping Features Deglutitive cricopharyngeus muscle dysfunction occurring predominantly in older adults and presenting with oropharyngeal dysphagia due to impaired upper esophageal sphincter opening during swallowing.
Distinguishing Features
  • Presents with swallowing difficulty (oropharyngeal dysphagia) in older adults rather than inability to belch in young adults.
  • Deglutitive upper esophageal sphincter relaxation is impaired in antegrade cricopharyngeus dysfunction but preserved in R-CPD.
Show evidence (1 reference)
PMID:31236539 SUPPORT Human clinical
"BT injection into the CPM has been previously reported for a different condition: a swallowing problem seen mostly in older persons caused by antegrade CPD (A-CPD).5-7 In the senior author’s extensive experience with that condition, A-CPD is much better treated with cricopharyngeus myotomy, and..."
Distinguishes R-CPD from antegrade cricopharyngeus dysfunction by preservation of swallowing and distinct clinical demographics.
{ }

Source YAML

click to show 
name: Retrograde Cricopharyngeus Dysfunction
creation_date: '2026-01-10T00:29:46Z'
updated_date: '2026-10-16T23:20:00Z'
description: An upper esophageal sphincter motility disorder characterized by the inability to belch due to reflex-specific failure of the cricopharyngeus muscle to relax in response to retrograde esophageal gaseous distension, while antegrade swallowing relaxation remains intact. Unvented intraesophageal gas triggers secondary peristalsis and passes distally, producing the cardinal symptom complex of inability to belch (abelchia), socially awkward gurgling noises in the chest and neck, abdominal bloating and distension, retrosternal chest pain, excessive flatulence, nausea, and painful hiccups.
category: Syndromic
parents:
- Neuromuscular Disorder
- Gastrointestinal Disorder

disease_term:
  preferred_term: retrograde cricopharyngeus dysfunction
  term:
    id: MONDO:0100099
    label: retrograde cricopharyngeus dysfunction
synonyms:
- abelchia
- no-burp syndrome
- retrograde cricopharyngeal dysfunction
- retrograde upper esophageal sphincter dysfunction
- inability to belch syndrome
- R-CPD

classifications:
  harrisons_chapter:
  - classification_value: GASTROINTESTINAL
    notes: Upper esophageal sphincter (cricopharyngeus muscle) motility disorder characterized by selective failure of the retrograde belch reflex during gaseous esophageal distension.
    evidence:
    - reference: PMID:35122356
      reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention"
      explanation: Establishes R-CPD as a gastrointestinal motility disorder of upper esophageal sphincter retrograde function.
prevalence:
- population: Global published clinical cohorts
  measure_type: CASES_IN_LITERATURE
  prevalence_class: UNKNOWN
  notes: True population prevalence has not been established in epidemiological surveys. A 2025 systematic review compiled 826 published cases across 17 studies with balanced sex distribution, though clinical series note substantial underdiagnosis and rapid growth in patient-initiated presentations via online communities.
  evidence:
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ResultsSeventeen studies met the inclusion criteria (826 patients)."
    explanation: Quantifies the total published clinical cohort size across 17 studies in the 2025 systematic review.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Conclusion and relevanceR-CPD is a recently-recognized and likely-underdiagnosed condition associated with severe symptoms affecting the quality of life of patients."
    explanation: Notes that true population prevalence remains underestimated because R-CPD is newly recognized and underdiagnosed.
  - reference: PMID:38256547
    reference_title: "Retrograde Cricopharyngeal Dysfunction: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A recent increase in awareness through patient-led social media discussion boards describing the 'no burp' syndrome is leading to an increasing incidence of presentations, often with patients making a self-diagnosis."
    explanation: Explains the rising clinical recognition and self-referral pattern driven by patient awareness.

progression:
- phase: Infancy and early childhood onset
  age_range: Infancy to childhood
  notes: Many patients have a lifelong or potentially congenital inability to burp, with parental reports of inability to be burped in infancy accompanied by colic, projectile vomiting, or excessive gas in 29% to 64.2% of cases.
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At least 15 (29%) had been told they could not be burped in infancy and had colic, projectile vomiting, or “incredible gassiness.”"
    explanation: Documents infantile onset of inability to burp and associated feeding symptoms in the index cohort.
  - reference: PMID:39883449
    reference_title: "Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sixty-eight patients (64.2%) had potential congenital R-CPD, according to the parents' testimonies."
    explanation: Prospective series showing nearly two-thirds of patients had parentally reported congenital onset.
- phase: Adolescent symptom amplification and adult diagnosis
  age_range: Adolescence to young adulthood (mean onset 13.6 years; mean diagnosis ~30 years)
  notes: While inability to burp is often lifelong, distressing secondary symptoms (bloating, gurgling, chest pain, flatulence) typically intensify during childhood or adolescence (mean age 13.6 years), followed by a prolonged diagnostic delay until young adulthood (mean age ~30 years).
  evidence:
  - reference: PMID:39883449
    reference_title: "Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Their mean (SD) age at symptom onset was 13.6 (7.7) years, and at diagnosis, 30.4 (6.4) years."
    explanation: Quantifies mean age of symptomatic onset in early adolescence and diagnostic delay into the fourth decade.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A family history was reported in 28.0% of cases with most patients developing R-CDP symptoms in childhood (55.5%)."
    explanation: Systematic review confirming that over half of patients develop symptoms in childhood.
  - reference: PMID:38256547
    reference_title: "Retrograde Cricopharyngeal Dysfunction: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Complaints often start during adolescence, and many patients search for a diagnosis for years before obtaining treatment."
    explanation: Highlights adolescent symptom escalation and multi-year diagnostic delay.

clinical_burden:
  burden_level: MODERATE
  rationale: Although non-fatal, R-CPD causes daily physical discomfort (bloating, chest pain) and substantial psychosocial morbidity—including social anxiety, embarrassment over loud gurgling and flatulence, dietary restrictions, work disruption, and relationship strain—compounded by widespread under-recognition among clinicians.
  evidence:
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Average Likert scores indicated embarrassment (3.4), anxiety/depression (3.1), negative impact on relationships (2.6), and work disruption (2.7) due to R-CPD."
    explanation: Quantifies the psychosocial, emotional, interpersonal, and occupational burden of R-CPD in a 199-patient survey.
  - reference: PMID:38256547
    reference_title: "Retrograde Cricopharyngeal Dysfunction: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "RCPD negatively impacts patients' quality of life and is associated with bloating, gurgling, avoidance of carbonation, self-imposed dietary and lifestyle changes designed to minimize discomfort, and flatulence."
    explanation: Summarizes quality-of-life impairment and restrictive lifestyle adaptations required to manage daily symptoms.
inheritance:
- name: Sporadic
  inheritance_term:
    preferred_term: Sporadic
    term:
      id: HP:0003745
      label: Sporadic
  description: Roughly 71% to 72% of patients present sporadically without a known family history of inability to belch.
  evidence:
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A family history was reported in 28.0% of cases with most patients developing R-CDP symptoms in childhood (55.5%)."
    explanation: Systematic review indicates that the majority (~72%) of cases occur without a reported family history.
- name: Non-Mendelian Familial Aggregation
  inheritance_term:
    preferred_term: Non-Mendelian inheritance
    term:
      id: HP:0001426
      label: Non-Mendelian inheritance
  description: Approximately 28% to 29% of patients report affected family members, suggesting a heritable predisposition in a subset of cases; no causative Mendelian gene has been identified, and positive family history predicts lower single-injection botulinum toxin success.
  evidence:
  - reference: PMID:39883449
    reference_title: "Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A family history was reported in 18 of 62 cases (29.0%)."
    explanation: Documents familial clustering in 29.0% of evaluated patients in a prospective clinical cohort.
  - reference: PMID:39883449
    reference_title: "Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Family history of R-CPD was a negative predictor of single-BTI success."
    explanation: Identifies familial R-CPD as clinically distinct in having a higher rate of incomplete response to a single botulinum toxin injection.
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "What is the familial incidence of R-CPD? Several patients mentioned a family member with the same problem."
    explanation: Notes familial occurrence in the initial description of R-CPD.

phenotypes:
- name: Inability to Belch
  description: Complete or near-complete inability to belch (eructate), which is the cardinal feature of R-CPD. Patients cannot voluntarily or reflexively release gas from the esophagus through the pharynx.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Inability to belch
    term:
      id: HP:0025031
      label: Abnormality of the digestive system
    coarse_binding_basis: NO_HPO_TERM
    term_gap: HPO has Belching (HP:0025262) and Aerophagia (HP:0031594) under Abnormality of digestive system physiology (HP:0025032), but no term for inability to belch (abelchia / retrograde eructation failure).
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"
    explanation: This landmark paper defined R-CPD and established inability to belch as the cardinal feature.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
    explanation: The Pavesi 2023 case report reiterates inability to burp as the defining symptom of R-CPD.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The incapacity to belch is the hallmark of the disease."
    explanation: The Jiménez-Castillo 2025 series states the hallmark symptom is inability to belch.
  - reference: PMID:36054518
    reference_title: "Retrograde Cricopharyngeus Dysfunction: The Jefferson Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The inability to burp (98.8%), bloating (92.9%), gurgling noises (31.8%), and excessive flatulence (21.2%) were the most common symptoms."
    explanation: The Jefferson case series quantifies inability to burp as the dominant presenting symptom.
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
    explanation: Survey data reinforce inability to burp as near-universal among affected patients.
- name: Abdominal Distention
  description: Abdominal bloating and distension due to trapped air that cannot be expelled through belching.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Abdominal distention
    term:
      id: HP:0003270
      label: Abdominal distention
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
    explanation: Bloating (abdominal distention) is described as part of the core symptom complex of R-CPD.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
    explanation: The Pavesi 2023 case report lists abdominal bloating as a key symptom.
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
    explanation: Community survey data show abdominal bloating affects nearly all respondents with R-CPD.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the cardinal symptom of the inability to belch, associated complaints of bloating and chest pain, gurgling noises, and excessive flatulence were found in 95.7%, 86%, and 80.2% of cases, respectively."
    explanation: Systematic review of 826 patients confirming bloating/chest pain in 95.7% of cases.
- name: Chest Pain
  description: Retrosternal chest discomfort, pressure, or sharp pain, particularly after eating, related to gaseous distension of the esophagus.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Chest pain
    term:
      id: HP:0100749
      label: Chest pain
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
    explanation: Chest pain is identified as a core symptom of retrograde UES dysfunction.
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
    explanation: Documents sharp central chest pain as part of the distension-related symptom complex in 49 of 51 patients.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the cardinal symptom of the inability to belch, associated complaints of bloating and chest pain, gurgling noises, and excessive flatulence were found in 95.7%, 86%, and 80.2% of cases, respectively."
    explanation: Systematic review confirming high prevalence of chest pain and bloating across 17 studies.
- name: Nausea
  description: Nausea, often occurring after meals due to air entrapment and inability to release gastric gas.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Nausea
    term:
      id: HP:0002018
      label: Nausea
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
    explanation: Nausea is described as part of the symptom complex associated with R-CPD.
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
    explanation: Notes postprandial nausea accompanying esophageal and gastric gaseous distension.
- name: Gurgling Sounds
  description: Socially awkward gurgling noises from the chest and lower neck as the esophagus churns attempting to expel trapped air.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Gurgling sounds in neck and chest
    term:
      id: HP:0025031
      label: Abnormality of the digestive system
    coarse_binding_basis: NO_HPO_TERM
    term_gap: HPO has no term for audible esophageal or retrosternal gurgling noises (borborygmi-like sounds in the lower neck and chest due to trapped esophageal gas).
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"
    explanation: Loud gurgling noises are described as a core feature of R-CPD.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
    explanation: Gurgling noises from the chest and lower neck are highlighted among the presenting symptoms.
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
    explanation: Survey responses show gurgling noises are frequent in R-CPD.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the cardinal symptom of the inability to belch, associated complaints of bloating and chest pain, gurgling noises, and excessive flatulence were found in 95.7%, 86%, and 80.2% of cases, respectively."
    explanation: Systematic review of 826 patients reporting gurgling noises in 86% of cases.
- name: Excessive Flatulence
  description: Excessive flatus resulting from swallowed and gastric gas that cannot be vented orally via belching and must transit the entire gastrointestinal tract.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Excessive flatulence
    term:
      id: HP:0033589
      label: Flatulence
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The fourth primary symptom comprising the syndrome of R-CPD was less universal and found in 43 of 51: excessive flatulence."
    explanation: Identifies excessive flatulence in 43 of 51 (84%) patients in the original R-CPD cohort.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the cardinal symptom of the inability to belch, associated complaints of bloating and chest pain, gurgling noises, and excessive flatulence were found in 95.7%, 86%, and 80.2% of cases, respectively."
    explanation: Systematic review of 826 patients reporting excessive flatulence in 80.2% of cases.
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
    explanation: Survey of 199 affected adults reporting excessive flatulence in 89% of respondents.
- name: Hiccups
  description: Recurrent or painful hiccups (singultus) associated with gaseous esophageal and gastric distension.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Painful hiccups
    term:
      id: HP:0100247
      label: Recurrent singultus
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
    explanation: Lists hiccups as part of the associated symptom complex of R-CPD.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
    explanation: Highlights painful hiccups among the characteristic symptoms of R-CPD.

pathophysiology:
- name: Failure of Upper Esophageal Sphincter Relaxation
  description: The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  cell_types:
  - preferred_term: muscle cell
    modifier: ABNORMAL
    term:
      id: CL:0000187
      label: muscle cell
  - preferred_term: sensory neuron
    modifier: ABNORMAL
    term:
      id: CL:0000101
      label: sensory neuron
  biological_processes:
  - preferred_term: regulation of muscle contraction
    modifier: ABNORMAL
    term:
      id: GO:0006937
      label: regulation of muscle contraction
  - preferred_term: skeletal muscle contraction
    modifier: ABNORMAL
    term:
      id: GO:0003009
      label: skeletal muscle contraction
  locations:
  - preferred_term: upper esophageal sphincter
    term:
      id: UBERON:0007268
      label: upper esophageal sphincter
  - preferred_term: cricopharyngeus muscle
    term:
      id: UBERON:0010928
      label: cricopharyngeus muscle
  downstream:
  - target: Intraesophageal Gas Trapping
    causal_link_type: DIRECT
    description: Failure of the cricopharyngeus muscle to relax during retrograde gas venting traps air within the esophageal body, equalizing esophageal and gastric pressures and producing low-pressure esophageal distension.
    evidence:
    - reference: PMID:38767031
      reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: "We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."
      explanation: High-resolution manometry with carbonated water provocation demonstrates that absent UES relaxation leads directly to elevated intraesophageal pressure from trapped gas.
  - target: Inability to Belch
    causal_link_type: DIRECT
    description: Absent retrograde upper esophageal sphincter relaxation directly prevents air venting across the cricopharyngeus muscle, resulting in complete inability to belch.
    evidence:
    - reference: PMID:35122356
      reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention"
      explanation: Directly links failure of UES relaxation after gastric gas venting to the inability to belch.
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention"
    explanation: The Kahrilas 2022 review establishes that UES relaxation failure during retrograde gas events is the core pathophysiological mechanism.
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
    explanation: The Yousef 2024 case-control study demonstrated physiological abnormalities in UES function in R-CPD patients.
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."
    explanation: The Dealino 2026 cases document absent UES relaxation during attempted belching.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."
    explanation: The Jiménez-Castillo 2025 case series shows failure of UES relaxation during retrograde distension.

- name: Elevated Upper Esophageal Sphincter Basal Pressure
  description: Preoperative high-resolution manometry case-control data show that R-CPD is associated with a significantly longer upper esophageal sphincter high-pressure zone and elevated resting basal pressure compared to asymptomatic controls; whether this resting hypertonicity directly raises the mechanical threshold for retrograde opening or co-occurs with a central defect of the belch reflex remains unresolved.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  cell_types:
  - preferred_term: muscle cell
    modifier: ABNORMAL
    term:
      id: CL:0000187
      label: muscle cell
  biological_processes:
  - preferred_term: muscle contraction
    modifier: INCREASED
    term:
      id: GO:0006936
      label: muscle contraction
  locations:
  - preferred_term: upper esophageal sphincter
    term:
      id: UBERON:0007268
      label: upper esophageal sphincter
  - preferred_term: cricopharyngeus muscle
    term:
      id: UBERON:0010928
      label: cricopharyngeus muscle
  downstream:
  - target: Failure of Upper Esophageal Sphincter Relaxation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Elevated resting cricopharyngeus pressure and increased sphincter length are manometrically associated with R-CPD and may increase the mechanical threshold against retrograde upper esophageal sphincter opening, although a direct causal contribution beyond the reflex-specific relaxation defect has not been established.
    evidence:
    - reference: PMID:38587015
      reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: "RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
      explanation: Demonstrates significantly increased UES length and resting basal pressure associated with R-CPD compared to asymptomatic controls, supporting a provisional link to impaired retrograde opening.
  evidence:
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
    explanation: The case-control study quantified significantly greater UES length (4.5 vs 3.7 cm) and higher UES basal pressures (91.9 vs 49.7 mm Hg) in R-CPD patients relative to controls.
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."
    explanation: Elevated resting UES pressure was observed in both cases in the 2026 report.

- name: Intraesophageal Gas Trapping
  description: When gastric gas vents across the lower esophageal sphincter into the esophageal body during a transient lower esophageal sphincter relaxation, failure of the upper esophageal sphincter to open traps the air bolus in the esophagus, equalizing esophageal pressure with gastric pressure and causing low-pressure gaseous esophageal distension and dilation.
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  locations:
  - preferred_term: esophagus
    term:
      id: UBERON:0001043
      label: esophagus
  downstream:
  - target: Secondary Peristalsis
    causal_link_type: DIRECT
    description: Gaseous distension and pressure equalization within the esophageal body from unvented air trigger repetitive secondary peristaltic contractions to sweep the trapped gas bolus distally.
    evidence:
    - reference: PMID:38767031
      reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: "We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."
      explanation: High-resolution manometry with carbonated water provocation demonstrates that intraesophageal pressure elevation from unvented gas triggers secondary peristalsis.
  - target: Chest Pain
    causal_link_type: DIRECT
    description: Pressurized gaseous distension of the esophagus produces sharp retrosternal chest discomfort.
    evidence:
    - reference: PMID:31236539
      reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
      explanation: Attributes sharp central chest pain to gaseous distension of the esophagus.
  - target: Abdominal Distention
    causal_link_type: DIRECT
    description: Unvented gas retained in the upper gastrointestinal tract and returned distally into the stomach and intestines causes progressive abdominal bloating and distension.
    evidence:
    - reference: PMID:31236539
      reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
      explanation: Connects unvented gas in the esophagus, stomach, and intestines to abdominal bloating and distension.
  - target: Excessive Flatulence
    causal_link_type: DIRECT
    description: Unvented upper gastrointestinal gas that cannot be expelled orally transits the intestinal tract and is expelled as excessive flatus.
    evidence:
    - reference: PMID:31236539
      reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The fourth primary symptom comprising the syndrome of R-CPD was less universal and found in 43 of 51: excessive flatulence."
      explanation: Documents excessive flatulence as the fourth primary symptom resulting from unvented gastrointestinal gas in R-CPD.
  - target: Nausea
    causal_link_type: DIRECT
    description: Postprandial gaseous distension of the esophagus and stomach triggers nausea.
    evidence:
    - reference: PMID:31236539
      reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
      explanation: Links postprandial nausea to gaseous distension of the upper gastrointestinal tract.
  - target: Hiccups
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Hiccups occur as part of the associated R-CPD symptom complex inferred to result downstream of unvented gaseous esophageal and gastric distension, although the intermediate reflex pathway is not directly characterized in the R-CPD literature.
    evidence:
    - reference: PMID:35122356
      reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
      supports: SUPPORT
      evidence_source: OTHER
      directness: INDIRECT
      snippet: "The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
      explanation: Identifies hiccups as part of the downstream symptom complex associated with retrograde UES dysfunction and esophageal gas distension.
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Indeed, prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention."
    explanation: Establishes that failure of UES relaxation after gastric gas venting results in low-pressure gaseous esophageal distension.
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patulous esophagus. The cricopharyngeus muscle (CPM) is being retracted posteriorly with a suction cannula (under arrow). As an unvalidated observation, the esophagus seen beyond the CPM typically appears to be abnormally open and even dilated."
    explanation: Endoscopic observation in the original R-CPD cohort notes an abnormally open and dilated esophageal lumen distal to the cricopharyngeus muscle consistent with chronic gas trapping.
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Another symptom comprising the syndrome and found in 49 of 51 were discomforts that might be speculated as due to distention of the esophagus, stomach, and intestines: central sharp chest pain, abdominal bloating and distention, and occasionally nausea, especially after eating."
    explanation: Links trapped gas and resulting distension of the esophagus, stomach, and intestines to the downstream clinical syndrome.

- name: Secondary Peristalsis
  description: Repetitive secondary peristaltic contractions of the esophageal body are triggered in response to intraesophageal gaseous distension and elevated esophageal pressure when the upper esophageal sphincter fails to relax during attempted belching, sweeping the trapped air bolus distally back toward the stomach.
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  biological_processes:
  - preferred_term: peristalsis
    modifier: INCREASED
    term:
      id: GO:0030432
      label: peristalsis
  locations:
  - preferred_term: esophagus
    term:
      id: UBERON:0001043
      label: esophagus
  downstream:
  - target: Gurgling Sounds
    causal_link_type: DIRECT
    description: Oscillating intraesophageal gas propelled by secondary peristalsis against a closed upper esophageal sphincter generates audible retrosternal and cervical gurgling noises.
    evidence:
    - reference: PMID:38767031
      reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "During the study, he reported an incapacity to belch and his symptoms coincided with increased esophageal pressure, an absence of UES relaxation, and secondary peristalsis."
      explanation: Links patient-reported symptoms during provocative testing with increased esophageal pressure, absent UES relaxation, and secondary peristalsis.
    - reference: PMID:31236539
      reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "A third primary symptom, found in 50 of 51, was gurgling noises from the chest and lower neck or abdomen."
      explanation: Documents audible gurgling noises from the chest and lower neck as a near-universal primary symptom of R-CPD.
  evidence:
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."
    explanation: Demonstrates on provocative high-resolution manometry that secondary peristalsis occurs when the patient experiences the need to belch against an unrelaxed UES.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We encourage the use of HRM, looking for an increase in esophageal pressure to the level of gastric pressure, failure of UES relaxation with consequently no venting of air across the UES, and secondary peristalsis."
    explanation: Defines secondary peristalsis following esophageal pressure equalization and absent UES relaxation as part of the characteristic manometric triad of R-CPD.

- name: Ineffective Esophageal Motility
  description: Preoperative high-resolution impedance manometry case-control data show a high prevalence of ineffective esophageal motility in R-CPD, characterized by elevated rates of ineffective swallows and incomplete bolus clearance; whether this hypomotility is a primary contributor to impaired gas clearance or a secondary consequence of chronic gaseous esophageal distension and dilation remains unresolved.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  biological_processes:
  - preferred_term: peristalsis
    modifier: DECREASED
    term:
      id: GO:0030432
      label: peristalsis
  locations:
  - preferred_term: esophagus
    term:
      id: UBERON:0001043
      label: esophagus
  downstream:
  - target: Intraesophageal Gas Trapping
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Impaired esophageal body clearance and high rates of ineffective swallows are manometrically associated with R-CPD and may contribute to intraesophageal gas and bolus retention, although causality could also run in the reverse direction from chronic esophageal distension.
    evidence:
    - reference: PMID:38587015
      reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: "Patients with RCPD demonstrated higher rates of ineffective swallows [70.0% (31.6%) vs 15.4% (21.6%), P < .001] and incomplete bolus clearance [81% (22.0%) vs 21.8% (30.0%), P < .001]."
      explanation: Quantifies markedly elevated rates of ineffective swallows (70.0% vs 15.4%) and incomplete bolus clearance (81% vs 21.8%) associated with R-CPD on preoperative manometry.
  evidence:
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
    explanation: Establishes ineffective esophageal motility as a key manometric abnormality associated with R-CPD.
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients with RCPD demonstrated higher rates of ineffective swallows [70.0% (31.6%) vs 15.4% (21.6%), P < .001] and incomplete bolus clearance [81% (22.0%) vs 21.8% (30.0%), P < .001]."
    explanation: Provides case-control quantitative evidence of impaired peristaltic swallows and bolus clearance in R-CPD patients.

treatments:
- name: Botulinum Toxin Injection
  description: Injection of botulinum toxin type A (typically 50 to 100 units, with efficacy reported down to 10 units) into the cricopharyngeus muscle via operating-room rigid or flexible esophagoscopy or awake in-office electromyography-guided percutaneous/transtracheal approaches. Temporary chemodenervation relaxes the upper esophageal sphincter, serving as both a confirmatory diagnostic test and definitive therapy that frequently leads to durable reflex retraining beyond the pharmacologic half-life of the toxin.
  treatment_term:
    preferred_term: botulinum toxin type A therapy
    term:
      id: NCIT:C157775
      label: Botulinum Toxin Therapy
    therapeutic_agent:
    - preferred_term: botulinum toxin type A
      term:
        id: CHEBI:3160
        label: Botulinum toxin type A
  therapeutic_modality: OTHER
  target_mechanisms:
  - target: Failure of Upper Esophageal Sphincter Relaxation
    treatment_effect: INHIBITS
    description: Chemodenervation of the cricopharyngeus muscle blocks presynaptic acetylcholine release, lowering sphincter resistance to permit retrograde gas venting and durable central reprogramming of the belch reflex.
    evidence:
    - reference: PMID:31236539
      reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "All 51 patients achieved ability to belch and relief of associated symptoms, and the majority seem to have \"retrained\" the ability to belch on a potentially \"permanent\" basis."
      explanation: Demonstrates that botulinum toxin injection restores retrograde UES relaxation and induces durable belch retraining.
  target_phenotypes:
  - preferred_term: Inability to belch
    term:
      id: HP:0025031
      label: Abnormality of the digestive system
    coarse_binding_basis: NO_HPO_TERM
    term_gap: HPO lacks a specific term for inability to belch (abelchia).
  - preferred_term: Socially awkward gurgling noises
    term:
      id: HP:0025031
      label: Abnormality of the digestive system
    coarse_binding_basis: NO_HPO_TERM
    term_gap: HPO lacks a specific term for esophageal or cervical gurgling sounds.
  - preferred_term: Abdominal bloating and distension
    term:
      id: HP:0003270
      label: Abdominal distention
  - preferred_term: Chest pain
    term:
      id: HP:0100749
      label: Chest pain
  - preferred_term: Excessive flatulence
    term:
      id: HP:0033589
      label: Flatulence
  effect_modifiers:
  - effect_modifier_type: OTHER
    stratum: Patients with positive family history of R-CPD
    comparator_stratum: Patients without family history of R-CPD
    modified_outcome: Single-injection botulinum toxin symptom resolution
    effect_in_stratum: SMALLER_EFFECT
    modification_analysis: POST_HOC_SUBGROUP
    description: A positive family history of R-CPD is associated with reduced likelihood of symptom resolution after a single in-office botulinum toxin injection.
    evidence:
    - reference: PMID:39883449
      reference_title: "Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Family history of R-CPD was a negative predictor of single-BTI success."
      explanation: Identifies family history of R-CPD as a negative predictor of single-injection botulinum toxin efficacy.
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All 51 patients achieved ability to belch and relief of associated symptoms, and the majority seem to have \"retrained\" the ability to belch on a potentially \"permanent\" basis."
    explanation: The Bastian 2019 case series demonstrated 100% success rate with botulinum toxin injection in restoring belching ability.
  - reference: DOI:10.1177/2473974x20938342
    reference_title: "The Long‐term Efficacy of Botulinum Toxin Injection to Treat Retrograde Cricopharyngeus Dysfunction"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a case series of 200 patients with retrograde cricopharyngeus dysfunction, 99% experienced relief of the cardinal symptoms and 79.9% experienced lasting relief of their symptoms beyond pharmacologic duration of action after a single injection of botulinum toxin into the cricopharyngeus muscle."
    explanation: The Hoesli 2020 200-patient follow-up cohort establishes 99% initial relief and 79.9% durable symptom resolution at 6 or more months after a single botulinum toxin injection.
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients who underwent cricopharyngeal botulinum injections experienced initial improvement of symptoms with 3 patients requiring repeat intervention."
    explanation: The Yousef 2024 study confirms botulinum toxin as an effective treatment.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "successfully treated with unilateral, anesthesia-free injection of 10 units of onabotulinum toxin into the cricopharyngeus muscle, representing the lowest dose reported to date."
    explanation: The Pavesi 2023 case report demonstrates symptom resolution with low-dose botulinum toxin.
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "previously undergone percutaneous botulinum toxin injection that initially provided temporary relief."
    explanation: The Dealino 2026 case notes symptomatic improvement after botulinum toxin injection.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The immediate success rate of botulinum toxin injection into the cricopharyngeal sphincter in facilitating burping was 92.5%."
    explanation: Systematic review reports high immediate success for botulinum toxin in R-CPD.
  - reference: PMID:39883449
    reference_title: "Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The cumulative success rate of BTI was 90.6% (96 of 106 patients)."
    explanation: In-office botulinum injections achieved high cumulative success in a 106-patient series.
  - reference: PMID:38576368
    reference_title: "Retrograde Cricopharyngeus Dysfunction, a New Motility Disorder: Single Center Case Series and Treatment Results."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At median follow-up of 29 months (range, 3-50) post-treatment, 51.3% (n = 20/39) of patients reported persistent complete relief of symptoms"
    explanation: Belgian case series quantifies short- and long-term response rates to botulinum toxin.

- name: Endoscopic Cricopharyngeal Myotomy
  description: Surgical or endoscopic division of the cricopharyngeus muscle fibers reserved for patients with refractory R-CPD whose symptoms recur after botulinum toxin injections or who are intolerant of repeated injections.
  treatment_term:
    preferred_term: cricopharyngeal myotomy
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  therapeutic_modality: SURGERY
  target_mechanisms:
  - target: Failure of Upper Esophageal Sphincter Relaxation
    treatment_effect: BYPASSES
    description: Myotomy permanently divides the cricopharyngeus muscle barrier, allowing retrograde esophageal gas venting in botulinum-refractory cases.
    evidence:
    - reference: PMID:41506952
      reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The second case involves a 30-year-old female with refractory symptoms who was effectively managed with endoscopic cricopharyngeal myotomy. She had previously undergone percutaneous botulinum toxin injection that initially provided temporary relief."
      explanation: Demonstrates effective surgical resolution of refractory R-CPD via endoscopic cricopharyngeal myotomy after temporary response to botulinum toxin.
  target_phenotypes:
  - preferred_term: Inability to belch
    term:
      id: HP:0025031
      label: Abnormality of the digestive system
    coarse_binding_basis: NO_HPO_TERM
    term_gap: HPO lacks a specific term for inability to belch (abelchia).
  evidence:
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The second case involves a 30-year-old female with refractory symptoms who was effectively managed with endoscopic cricopharyngeal myotomy. She had previously undergone percutaneous botulinum toxin injection that initially provided temporary relief."
    explanation: Documents successful management of botulinum-refractory R-CPD with endoscopic cricopharyngeal myotomy.
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "For refractory cases and those intolerant of repeated injections, more extensive surgery, including cricopharyngeal myotomy, may be offered."
    explanation: Establishes cricopharyngeal myotomy as a salvage surgical option for refractory R-CPD.
  - reference: DOI:10.1177/2473974x20938342
    reference_title: "The Long‐term Efficacy of Botulinum Toxin Injection to Treat Retrograde Cricopharyngeus Dysfunction"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of those who did not maintain the ability, 12 underwent a second injection, 1 patient underwent 3 subsequent injections, and 3 patients underwent partial myotomy."
    explanation: Documents partial cricopharyngeus myotomy as a salvage intervention among patients whose symptoms recurred after botulinum toxin injection in the 200-patient series.
  - reference: DOI:10.1002/oto2.70014
    reference_title: "Diagnosis and Management of Retrograde Cricopharyngeal Dysfunction: A Systematic Review"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Six patients ultimately received CP myotomy for recurrent symptoms, resulting in long‐term resolution in 4 (67%) patients."
    explanation: Systematic review summarizing outcomes of cricopharyngeal myotomy for recurrent R-CPD across published series.

diagnosis:
- name: Syndromic Clinical Diagnosis and Therapeutic Botulinum Toxin Trial
  description: Primary diagnosis is established clinically from the characteristic symptom tetrad (inability to belch, retrosternal/cervical gurgling noises, abdominal bloating/distension, and excessive flatulence) and definitively validated by symptom resolution following cricopharyngeal botulinum toxin injection.
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "R-CPD can be diagnosed syndromically, using a symptom complex; clinical diagnosis is validated by relief of symptoms after BT injection; and BT into the CPM is an efficacious treatment, whose benefit appears to often last longer than the pharmacologic duration of action of BT."
    explanation: Establishes syndromic clinical diagnosis validated by response to cricopharyngeal botulinum toxin injection as the primary diagnostic paradigm for R-CPD.

- name: High-Resolution Impedance Manometry
  description: High-resolution impedance manometry (HRIM) with a provocative carbonated water challenge (e.g., 500 mL) objectively demonstrates increased esophageal pressure equilibrating with gastric pressure, absence of upper esophageal sphincter relaxation with no air venting across the UES, and repetitive secondary peristalsis, alongside elevated basal UES pressure and increased UES length.
  measurements:
  - preferred_term: high-resolution impedance manometry of the upper esophageal sphincter
    term:
      id: LOINC:51393-7
      label: Esophageal manometry study
  notes: >-
    LOINC codes esophageal manometry once, as a study whose result is a report, and
    that single record is what is bound: one match in the full LOINC 2.83 table and one
    in the Monarch KG, paginated to its stated total, with no Part. Two things it does
    not capture, recorded so the binding is not read as more than it is. The release
    has no high-resolution or impedance variant, so the modality this row specifies is
    not in the code. And it has no code for the provocative carbonated-water challenge
    that makes the test diagnostic here. The release's one quantitative
    esophageal pressure code, LOINC:60738-2, is a single intraluminal pressure rather
    than a manometry study and is not bound. No reference range is bound: the row's
    finding is failure of relaxation during distension, not a pressure threshold.
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The field has now further advanced with the publication in this issue of the Journal by Oude Nijhuis et al. of 8 cases of R-UESD demonstrated by high-resolution impedance manometry (HRIM) with a provocative challenge of carbonated water."
    explanation: HRIM with provocative testing provides objective diagnostic confirmation of R-CPD.
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Esophageal high-resolution impedance manometry was completed preoperatively in patients diagnosed with RCPD."
    explanation: HRIM is used for demonstrating UES abnormalities in R-CPD.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."
    explanation: HRM with belch provocation shows characteristic pressure rise and absent UES relaxation in R-CPD.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We encourage the use of HRM, looking for an increase in esophageal pressure to the level of gastric pressure, failure of UES relaxation with consequently no venting of air across the UES, and secondary peristalsis."
    explanation: Summarizes the diagnostic HRM criteria during belch provocation.

differential_diagnoses:
- name: Supragastric Belching
  description: Functional belching disorder characterized by repetitive supradiaphragmatic air influx and frequent belches, rather than an inability to vent esophageal gas.
  distinguishing_features:
  - Patients exhibit frequent, often repetitive belching episodes instead of inability to belch.
  - High-resolution manometry with belch provocation in R-CPD demonstrates an increase in esophageal pressure to the level of gastric pressure, failure of UES relaxation with no venting of air across the UES, and secondary peristalsis.
  evidence:
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The incapacity to belch is the hallmark of the disease."
    explanation: R-CPD is defined by inability to belch, distinguishing it from conditions like supragastric belching where belching is frequent.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We encourage the use of HRM, looking for an increase in esophageal pressure to the level of gastric pressure, failure of UES relaxation with consequently no venting of air across the UES, and secondary peristalsis."
    explanation: Establishes the characteristic high-resolution manometry findings of R-CPD during belch provocation.

- name: Antegrade Cricopharyngeus Dysfunction
  description: Deglutitive cricopharyngeus muscle dysfunction occurring predominantly in older adults and presenting with oropharyngeal dysphagia due to impaired upper esophageal sphincter opening during swallowing.
  distinguishing_features:
  - Presents with swallowing difficulty (oropharyngeal dysphagia) in older adults rather than inability to belch in young adults.
  - Deglutitive upper esophageal sphincter relaxation is impaired in antegrade cricopharyngeus dysfunction but preserved in R-CPD.
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "BT injection into the CPM has been previously reported for a different condition: a swallowing problem seen mostly in older persons caused by antegrade CPD (A-CPD).5-7 In the senior author’s extensive experience with that condition, A-CPD is much better treated with cricopharyngeus myotomy, and none of the patients with R-CPD reported here had any symptoms or findings of A-CPD."
    explanation: Distinguishes R-CPD from antegrade cricopharyngeus dysfunction by preservation of swallowing and distinct clinical demographics.

notes: >
  R-CPD was first formally named and syndromically defined in 2019 by Bastian
  and Smithson, after only three isolated physiological case reports of
  inability to belch (1987, 1991, and 2015) had been published in the prior
  literature. Despite typical symptom onset in infancy or early childhood and
  amplification in adolescence, patients historically underwent extensive
  non-diagnostic testing (esophagogastroduodenoscopy, barium esophagram, pH-impedance
  monitoring, gastric emptying studies) and empirical proton pump inhibitor or
  antispasmodic trials for presumed gastroesophageal reflux disease, irritable
  bowel syndrome, functional dyspepsia, or aerophagia before receiving a
  diagnosis at a mean age of 30.4 years. Most patients retain the ability to belch
  after a single cricopharyngeal botulinum toxin injection well beyond the
  expected 3-to-4-month pharmacologic duration of chemodenervation, indicating
  durable central or sensory-motor reprogramming of the retrograde upper
  esophageal sphincter reflex.
references:
- reference: DOI:10.1002/jpn3.12193
  title: Pediatric retrograde cricopharyngeal dysfunction diagnosed by high‐resolution impedance manometry
  findings: []
- reference: DOI:10.1002/ohn.735
  title: Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction
  findings: []
- reference: DOI:10.1002/oto2.70014
  title: 'Diagnosis and Management of Retrograde Cricopharyngeal Dysfunction: A Systematic Review'
  findings: []
- reference: DOI:10.1007/s00405-024-08644-7
  title: 'Cricopharyngeus muscle dysfunction: a poorly defined disorder from diagnosis to treatment'
  findings: []
- reference: DOI:10.1111/nmo.14328
  title: Retrograde upper esophageal sphincter function… and dysfunction
  findings: []
- reference: DOI:10.1152/ajpgi.00007.2012
  title: The role of the superior laryngeal nerve in esophageal reflexes
  findings: []
- reference: DOI:10.1152/ajpgi.00292.2018
  title: Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter
  findings: []
- reference: DOI:10.1177/19160216251329012
  title: 'Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review'
  findings: []
- reference: DOI:10.1177/2473974x19834553
  title: 'Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment'
  findings: []
- reference: DOI:10.1177/2473974x20938342
  title: The Long‐term Efficacy of Botulinum Toxin Injection to Treat Retrograde Cricopharyngeus Dysfunction
  findings: []
- reference: DOI:10.3389/fneur.2022.1005655
  title: 'Case report: A case of novel treatment for retrograde cricopharyngeal dysfunction'
  findings: []
📚

References & Deep Research

References

11
DOI:10.1002/jpn3.12193
Pediatric retrograde cricopharyngeal dysfunction diagnosed by high‐resolution impedance manometry
No top-level findings curated for this source.
DOI:10.1002/ohn.735
Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction
No top-level findings curated for this source.
DOI:10.1002/oto2.70014
Diagnosis and Management of Retrograde Cricopharyngeal Dysfunction: A Systematic Review
No top-level findings curated for this source.
DOI:10.1007/s00405-024-08644-7
Cricopharyngeus muscle dysfunction: a poorly defined disorder from diagnosis to treatment
No top-level findings curated for this source.
DOI:10.1111/nmo.14328
Retrograde upper esophageal sphincter function… and dysfunction
No top-level findings curated for this source.
DOI:10.1152/ajpgi.00007.2012
The role of the superior laryngeal nerve in esophageal reflexes
No top-level findings curated for this source.
DOI:10.1152/ajpgi.00292.2018
Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter
No top-level findings curated for this source.
DOI:10.1177/19160216251329012
Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review
No top-level findings curated for this source.
DOI:10.1177/2473974x19834553
Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment
No top-level findings curated for this source.
DOI:10.1177/2473974x20938342
The Long‐term Efficacy of Botulinum Toxin Injection to Treat Retrograde Cricopharyngeus Dysfunction
No top-level findings curated for this source.
DOI:10.3389/fneur.2022.1005655
Case report: A case of novel treatment for retrograde cricopharyngeal dysfunction
No top-level findings curated for this source.

Deep Research

2

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Review and enhance: Retrograde Cricopharyngeus Dysfunction · 2026-10-16T23:20:00Z · View source

Grounded review and enhancement of Retrograde Cricopharyngeus Dysfunction (MONDO:0100099) against the cyberian-codex and falcon deep research reports and cached PubMed/DOI primary and review articles: - Added clinical synonyms (abelchia, no-burp syndrome, retrograde cricopharyngeal dysfunction, retrograde upper esophageal sphincter dysfunction, inability to belch syndrome, R-CPD), Harrison's chapter classification (GASTROINTESTINAL), literature case prevalence (826 cases across 17 studies, PMID:40411338; true population prevalence unknown due to historical under-recognition; deprecated percentage field omitted), two-phase progression (infancy/early childhood onset and adolescent amplification with adult diagnosis at mean age 30.4 years), moderate clinical burden, and sporadic vs non-Mendelian familial aggregation inheritance patterns (29.0% familial clustering in 18 of 62 evaluated cases, PMID:39883449). - Added coarse_binding_basis (NO_HPO_TERM) and term_gap explanations to Inability to Belch and Gurgling Sounds (bound to HP:0025031), added Excessive Flatulence (HP:0033589) and Hiccups (HP:0100247), and populated evidence_source across all phenotype evidence items. - Expanded pathophysiology into a connected 5-node causal graph with biological_scale, mechanism_confidence, and downstream edges linking Elevated Upper Esophageal Sphincter Basal Pressure (PROVISIONAL), Failure of Upper Esophageal Sphincter Relaxation (ESTABLISHED), Intraesophageal Gas Trapping (ESTABLISHED), Secondary Peristalsis (ESTABLISHED), and Ineffective Esophageal Motility (PROVISIONAL) to downstream clinical phenotypes, with INDIRECT_UNKNOWN_INTERMEDIATES edges where causal directionality or intermediate reflex arcs are unresolved. - Enhanced Botulinum Toxin Injection with therapeutic_agent (CHEBI:3160), therapeutic_modality (OTHER), target_mechanisms, target_phenotypes, long-term 200-patient cohort outcomes (DOI:10.1177/2473974x20938342), and a familial-history effect modifier (PMID:39883449), and added Endoscopic Cricopharyngeal Myotomy (NCIT:C15329) for botulinum-refractory R-CPD (PMID:41506952, DOI:10.1177/2473974x20938342, DOI:10.1002/oto2.70014). - Added Syndromic Clinical Diagnosis and Therapeutic Botulinum Toxin Trial alongside High-Resolution Impedance Manometry in diagnosis, refined Supragastric Belching distinguishing features, and added Antegrade Cricopharyngeus Dysfunction to differential_diagnoses.

Disorder ▸

Disorder

  • Name: Retrograde Cricopharyngeus Dysfunction
  • Category: Syndromic
  • Existing deep-research providers: falcon
  • Existing evidence reference count in YAML: 42

Key Pathophysiology Nodes

  • Failure of Upper Esophageal Sphincter Relaxation
  • Elevated Upper Esophageal Sphincter Basal Pressure
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1002/jpn3.12193
  • DOI:10.1002/ohn.735
  • DOI:10.1002/oto2.70014
  • DOI:10.1007/s00405-024-08644-7
  • DOI:10.1111/nmo.14328
  • DOI:10.1152/ajpgi.00007.2012
  • DOI:10.1152/ajpgi.00292.2018
  • DOI:10.1177/19160216251329012
  • DOI:10.1177/2473974x19834553
  • DOI:10.1177/2473974x20938342
  • DOI:10.3389/fneur.2022.1005655
Falcon ▸
Disease Pathophysiology Research Report
Edison Scientific Literature 31 citations 2025-12-16T14:47:22.861792

Disease Pathophysiology Research Report

Target Disease

  • Disease Name: Retrograde Cricopharyngeus Dysfunction (R-CPD)
  • MONDO ID: MONDO:0100099 (if available)
  • Category: Syndromic

Pathophysiology description

Retrograde Cricopharyngeus Dysfunction is characterized by a failure of the upper esophageal sphincter (UES), largely constituted by the cricopharyngeus muscle, to relax in response to retrograde esophageal gaseous distension that normally triggers belching. High-resolution impedance manometry (HRIM) studies with provocative carbonated-water challenges demonstrate common-cavity pressurization from gastric gas reflux without the expected, complete UES relaxation and air venting, resulting in air trapping within the esophagus. Clinically this manifests as inability to belch with associated chest/neck gurgling, bloating, chest discomfort, and excessive flatulence (i.e., the “no-burp” syndrome). Botulinum toxin injection targeting the cricopharyngeus (CP) reproducibly restores belching and relieves symptoms, often with durability that outlasts the pharmacologic window, supporting a neuromuscular reflex-control failure rather than structural obstruction as the core mechanism (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).

Mechanistically, the normal belch sequence involves a transient lower esophageal sphincter relaxation with gas reflux and esophageal pressurization, followed by UES/CP relaxation and esophago-pharyngeal gas venting; HRIM and physiologic experiments indicate the UES relaxation is volume- and pressure-dependent and mediated by vagal and superior laryngeal nerve (SLN) pathways. In R-CPD, this retrograde UES relaxation fails despite preserved deglutitive UES relaxation, i.e., a reflex-specific deficit. This failure diverts gas clearance to secondary peristalsis, producing repeated audible gurgling and symptomatic air trapping (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3, xie2022casereporta pages 1-2).

Recent developments and latest research

  • Case-control HRIM (2024) showed R-CPD patients have significantly longer UES length and higher basal UES pressures versus age/sex-matched controls, plus increased ineffective swallows and incomplete bolus clearance, establishing objective physiologic correlates and coexisting esophageal dysmotility in some patients (Yousef et al., Otolaryngology–Head & Neck Surgery, Apr 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
  • Pediatric HRIM series (2024) described adolescents with normal deglutitive UES relaxation but abnormal UES relaxation with high impedance during carbonated drink challenge, consistent with selective failure of the belch reflex; all improved after CP botulinum injection (Journal of Pediatric Gastroenterology and Nutrition, Mar 2024; https://doi.org/10.1002/jpn3.12193) (xie2022casereporta pages 1-2).
  • Minireview (2022) synthesized evidence that HRIM with provocative testing can objectively demonstrate failure of UES relaxation during gaseous distension and that CP botulinum injection normalizes findings and relieves symptoms (Neurogastroenterology & Motility, Feb 2022; https://doi.org/10.1111/nmo.14328) (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Systematic reviews (2024–2025) summarize high immediate success rates of CP botulinum toxin and document typical symptom complex, while highlighting heterogeneity and the need for standardized diagnostic criteria and prospective outcomes research (OTO Open, Oct 2024; https://doi.org/10.1002/oto2.70014; Journal of Otolaryngology–Head & Neck Surgery, May 2025; https://doi.org/10.1177/19160216251329012) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

Current applications and real-world implementations

  • Diagnostic: HRIM with impedance plus provocative carbonated-water ingestion to elicit esophageal gas pressurization and assess for appropriate UES relaxation; selective failure of retrograde (but not swallow-related) UES relaxation supports R-CPD (yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, kahrilas2022retrogradeupperesophageal pages 1-3).
  • Therapeutic: EMG/endoscopic/ultrasound-guided botulinum toxin injection into the cricopharyngeus is both diagnostic and therapeutic; durable response in many patients; cricopharyngeal myotomy is a salvage option in recalcitrant cases (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).

Expert opinions and analysis from authoritative sources

  • “Failure of the UES to relax during retrograde gastroesophageal gas events (belching) leads to inability to vent esophago‑pharyngeal gas,” with HRIM evidence and response to botulinum toxin arguing for a reflex-control failure centered at the cricopharyngeus (Neurogastroenterology & Motility, 2022) (kahrilas2022retrogradeupperesophageal pages 4-6).
  • Systematic syntheses emphasize that botulinum toxin’s immediate success in enabling belching supports a neuromuscular pathophysiology, while variability in relapse highlights heterogeneity and potential coexisting motility disorders that merit stratified evaluation (2024–2025) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

Relevant statistics and data from recent studies

  • Large case series (n=200): 99.5% gained ability to burp after CP botulinum toxin; 95% relieved cardinal symptoms; 79.9% maintained satisfactory belching beyond 6 months after a single injection (OTO Open, Apr 2020; https://doi.org/10.1177/2473974x20938342) (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Systematic review (2025): Immediate success rate of botulinum toxin enabling burping 92.5%; transient dysphagia most common adverse event (31.1%); recurrences at >6 months in 27.9% (Journal of Otolaryngology–Head & Neck Surgery, May 2025; https://doi.org/10.1177/19160216251329012) (lechien2025etiologyclinicalpresentation pages 1-3).
  • Systematic review (2024): Across pooled reports, 86.9% improved after initial BTX; common initial dose 50 U; some required repeat injection or myotomy (OTO Open, Oct 2024; https://doi.org/10.1002/oto2.70014) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Case-control HRIM (2024): R-CPD vs controls—higher UES basal pressure (e.g., ~92 vs ~50 mmHg), longer UES, higher rates of ineffective swallows and incomplete bolus clearance; all treated patients had initial improvement after CP botulinum injection (Otolaryngology–Head & Neck Surgery, Apr 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
Study (first author, year) Design / Population Key Physiologic Findings (UES/CP behavior; HRIM metrics) Neural Reflex Insights Treatment Outcomes (botulinum toxin / myotomy) URL (with DOI) Publication date (month/year)
Kahrilas 2022 Minireview / case-series synthesis Failure of UES relaxation to retrograde gas; HRIM with carbonated-water provocation demonstrates absent UES relaxation despite common-cavity events Belch reflex: tLESR → esophageal pressurization → UES relaxation; reflex is pressure- and volume-dependent; complex vagal/SLN mediation (belch vs swallow differences) (kahrilas2022retrogradeupperesophageal pages 1-3) BTX to CPM restores belching in reported series; supports reflex failure rather than fixed obstruction (kahrilas2022retrogradeupperesophageal pages 1-3) https://doi.org/10.1111/nmo.14328 Feb 2022
Yousef 2024 Case-control HRIM study (R-CPD n=13 vs controls n=26) R-CPD: longer UES length and markedly higher UES basal pressures (mean ~92 mmHg vs ~50 mmHg); ↑ ineffective swallows and incomplete bolus clearance on HRIM (yousef2024upperesophagealsphincter pages 8-12) Supports impaired retrograde UES relaxation with concomitant esophageal motility abnormalities; suggests phenotypic heterogeneity (yousef2024upperesophagealsphincter pages 8-12) All treated with CP botulinum had initial improvement; some required repeat injections (yousef2024upperesophagealsphincter pages 8-12) https://doi.org/10.1002/ohn.735 Apr 2024
Dorfman 2024 (pediatric HRIM) Pediatric case series (adolescents with inability to burp) Normal deglutitive UES relaxation but abnormal UES relaxation to carbonated-drink provocation with high impedance indicating air entrapment; several had esophageal motility disorders (xie2022casereporta pages 1-2, yousef2024upperesophagealsphincter pages 8-12) Provocation HRIM shows selective failure of retrograde-triggered UES relaxation; supports reflex-specific dysfunction rather than global swallow failure (xie2022casereporta pages 1-2) Symptom improvement/resolution after BTX into CPM reported in cohort (xie2022casereporta pages 1-2) https://doi.org/10.1002/jpn3.12193 Mar 2024
Bastian 2019 Consecutive case series (n=51) Syndromic diagnostic criteria for R-CPD (inability to belch, gurgling, bloating); BTX injection into CPM produced restoration of burping in all patients; many retained function beyond expected pharmacologic window (kahrilas2022retrogradeupperesophageal pages 4-6) Clinical validation that targeted chemodenervation of CPM unmasks/refutes diagnosis; implies neuromuscular/reflex control locus at CPM (kahrilas2022retrogradeupperesophageal pages 4-6) 100% short-term success with BTX; many maintained long-term retrained belching; few required myotomy (kahrilas2022retrogradeupperesophageal pages 4-6) https://doi.org/10.1177/2473974x19834553 Mar 2019
Hoesli 2020 Large retrospective case series (first 200 patients treated) 99.5% gained ability to burp after BTX; 79.9% maintained satisfactory burping >6 months after single injection; supports durable functional recovery in many (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6) Outcome data implies functional reprogramming of reflex circuits or central adaptation after temporary CPM denervation (yousef2024upperesophagealsphincter pages 8-12) BTX injection safe; minority required repeat injections or partial myotomy (yousef2024upperesophagealsphincter pages 8-12) https://doi.org/10.1177/2473974x20938342 Apr 2020
Xie 2022 Single case report with HRM and guided BTX injection HRM: elevated UES residual pressure (22.6 mmHg; normal <12); imaging showed air trapping; post-BTX residual pressure normalized (5.5 mmHg) with symptom resolution (xie2022casereporta pages 1-2) Objective demonstration of selective failure of retrograde UES relaxation with normalization after targeted CPM chemodenervation (xie2022casereporta pages 1-2) Rapid, complete symptom resolution after BTX (50 U) with sustained effect at follow-up; supports diagnostic/therapeutic role of BTX (xie2022casereporta pages 1-2) https://doi.org/10.3389/fneur.2022.1005655 Dec 2022
Krekeler 2024 (review) Narrative review of CPM dysfunction Summarizes HRIM findings: abnormal retrograde UES relaxation, air entrapment on impedance, possible HRPM-I thresholds (e.g., abnormal relaxation pressure >8 mmHg) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) Highlights knowledge gaps in reflex circuitry but emphasizes vagal/SLN afferent roles and need for standardized diagnostic criteria (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) Reviews evidence for BTX as first-line; myotomy for refractory cases; calls for prospective trials (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) https://doi.org/10.1007/s00405-024-08644-7 May 2024
Lang 2012 Animal (decerebrate cat) experiments on SLN role Rapid esophageal distension triggers belch sequence with UES (CP) inhibition; distinct receptors (mucosal rapidly adapting vs muscular slowly adapting) evoke different UES responses (lang2012theroleof pages 11-12, lang2012theroleof pages 1-1) SLN afferents mediate CP inhibition component of belch; vagal afferents required for belch initiation; SLN transection abolishes CP inhibition while vagotomy abolishes belch (lang2012theroleof pages 11-12) Mechanistic/physiologic foundation explaining why CPM denervation (BTX) can restore venting by removing hyperactive CP tone (lang2012theroleof pages 11-12) https://doi.org/10.1152/ajpgi.00007.2012 Jun 2012
Lang 2019 Animal studies on esophageal acidification effects Short-term acid sensitizes EURR (esophago-UES relaxation reflex) and desensitizes EUCR; longer exposure inhibits EURR and EUCR—showing plasticity of reflexes (lang2019effectsofesophageal pages 18-23) Demonstrates that peripheral sensitization/desensitization (e.g., acid exposure) alters reflex thresholds controlling UES relaxation/contraction (lang2019effectsofesophageal pages 18-23) Implies reflux or mucosal afferent modulation could influence R-CPD phenotype or severity; therapeutic implications for modulating afferent input (lang2019effectsofesophageal pages 18-23) https://doi.org/10.1152/ajpgi.00292.2018 Jan 2019
Szczesniak 2008 Review of esophageal afferent pathways Describes vagal mechanoreceptors (IGLEs) and mucosal receptors mediating esophago-pharyngeal reflexes; evidence that mucosal anesthesia abolishes certain UES relaxations—underscoring sensory afferent dependence (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94) Highlights central afferent processing and pharmacologic modulation (e.g., GABAB effects on afferent traffic) that can block distension-induced UES responses (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94) Provides rationale for therapies targeting sensory modulation or central processing in addition to CPM-focused interventions (szczesniak2008…andpathophysiological pages 58-61) (review; DOI varies) 2008

Table: Evidence matrix summarizing key recent studies on Retrograde Cricopharyngeus Dysfunction (R-CPD), their physiologic findings, neural reflex insights, and treatment outcomes; useful for quickly locating mechanistic and clinical citations.

Core Pathophysiology

1) Primary mechanisms - Reflex-specific failure of UES/cricopharyngeus relaxation in response to abrupt proximal esophageal gaseous distension (belch trigger), despite normal deglutitive UES relaxation. This causes air trapping, common-cavity pressurization without pharyngeal venting, and compensatory secondary peristalsis with gurgling (Neurogastroenterology & Motility 2022; Otolaryngology–HNS 2024; J Pediatr Gastroenterol Nutr 2024) (kahrilas2022retrogradeupperesophageal pages 1-3, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, kahrilas2022retrogradeupperesophageal pages 3-4). - Elevated basal UES tone/length and frequent ineffective esophageal motility occur in a subset, potentially amplifying air entrapment and symptom severity (Otolaryngology–HNS 2024) (yousef2024upperesophagealsphincter pages 8-12). - Robust clinical and HRIM improvement after targeted CP chemodenervation with botulinum toxin implicates hypertonic CP muscle and/or aberrant reflex control as the operative defects (OTO Open 2019, 2020; Frontiers Neurol 2022) (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).

2) Dysregulated pathways - Esophago‑UES relaxation reflex (EURR) is blunted/absent in R-CPD, while esophago‑UES contraction reflex (EUCR) and secondary peristalsis compensate; animal studies demonstrate differential activation by rapid (mucosal) vs slow (muscularis) distension, and that SLN afferents mediate CP inhibition during belch whereas vagal afferents are essential for belch initiation (AJP-GI 2012; AJP-GI 2019) (lang2012theroleof pages 1-1, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23, lang2012theroleof pages 11-12). - Sensory modulation: esophageal acidification sensitizes EURR short-term but desensitizes both EURR and EUCR with prolonged exposure, highlighting plasticity that may modulate R-CPD phenotype (AJP-GI 2019) (lang2019effectsofesophageal pages 18-23). - Central/afferent modulation: GABA-B agonism reduces vagal afferent traffic and can block distension-induced UES responses, indicating GABAergic control over afferent gating (Szczesniak 2008) (szczesniak2008…andpathophysiological pages 88-94).

3) Affected cellular processes - Impaired neuromuscular inhibition of skeletal muscle (CP) during retrograde gas events; altered sensorimotor integration of vagal/SLN afferents with medullary nuclei coordinating UES relaxation and laryngeal closure; secondary peristalsis recruitment for gas clearance (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 11-12, lang2019effectsofesophageal pages 18-23).

Key Molecular Players

  • Genes/Proteins (evidence-based functional roles)
  • GABA-B receptor signaling (GABBR1/2; HGNC:4085/4086): pharmacologic activation (baclofen) dampens vagal afferent signaling and can inhibit distension-induced UES responses (szczesniak2008…andpathophysiological pages 88-94).
  • Mechanoreceptor apparatus of vagal afferents, notably intraganglionic laminar endings (IGLEs) in the muscularis, mediating EUCR/secondary peristalsis; rapidly adapting mucosal mechanoreceptors mediating belch/EURR (functional entities rather than single genes) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Chemical Entities (CHEBI)
  • Botulinum toxin type A (CHEBI:3603): chemodenervation of CP restores belching; high real-world efficacy (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).
  • Baclofen (CHEBI:2299): GABA-B agonist that reduces vagal afferent traffic and transient reflex relaxations in upper gut physiology (szczesniak2008…andpathophysiological pages 88-94).
  • Cell Types (CL)
  • Cricopharyngeus skeletal muscle fibers (striated muscle cells) (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3).
  • Vagal sensory neurons and SLN sensory fibers innervating esophageal mucosa/muscularis (lang2012theroleof pages 11-12, lang2012theroleof pages 6-7).
  • Brainstem medullary neurons coordinating reflexes (dorsal motor nucleus involvement described; central processing emphasized) (lang2012theroleof pages 11-12).
  • Anatomical Locations (UBERON)
  • Upper esophageal sphincter (UES) region and cricopharyngeus muscle of the inferior pharyngeal constrictor; proximal cervical esophagus; larynx/glottis (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3, lang2012theroleof pages 6-7).

Biological Processes (GO annotation candidates)

  • Esophago‑upper esophageal sphincter relaxation reflex (part of reflex-mediated smooth/striated muscle relaxation) (kahrilas2022retrogradeupperesophageal pages 3-4, lang2019effectsofesophageal pages 18-23).
  • Reflex regulation of skeletal muscle contraction/relaxation (UE S/CP) during gas venting (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 11-12).
  • Mechanosensory transduction in esophageal mucosa/muscularis (vagal/SLN afferents; IGLEs) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Secondary peristalsis and esophageal motility patterns (increased ineffective swallows; impaired bolus clearance) (yousef2024upperesophagealsphincter pages 8-12).
  • GABAergic modulation of vagal afferent signaling (szczesniak2008…andpathophysiological pages 88-94).

Cellular Components

  • Cricopharyngeus neuromuscular junctions and sarcomeric contractile apparatus (implied by CP hypertonia; generalized physiology contextualized to UES) (kahrilas2022retrogradeupperesophageal pages 1-3).
  • Esophageal mucosal mechanoreceptors and muscularis-layer IGLEs as afferent transducers (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Brainstem medullary nuclei (including dorsal motor nucleus) participating in reflex integration and output (lang2012theroleof pages 11-12).

Disease Progression

  • Initiating trigger: transient LES relaxation with gas reflux (or exogenous gas from carbonated drink) creates proximal esophageal pressurization (kahrilas2022retrogradeupperesophageal pages 3-4).
  • Physiologic bottleneck: UES/CP fails to exhibit complete reflex relaxation to retrograde gaseous distension (EURR impairment), despite normal swallow-related relaxation (kahrilas2022retrogradeupperesophageal pages 3-4, xie2022casereporta pages 1-2).
  • Compensatory patterns: secondary peristalsis and EUCR predominate; gas fails to vent, leading to repetitive gurgling and air entrapment (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 3-4).
  • Clinical manifestations: inability to belch, chest/neck gurgling, bloating/abdominal discomfort, chest pain, excessive flatulence, sometimes nausea/hiccups (kahrilas2022retrogradeupperesophageal pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).
  • Modifiers: Elevated basal UES pressure/length and ineffective esophageal motility may worsen severity; peripheral sensitization/desensitization (acid exposure) may shift reflex thresholds (yousef2024upperesophagealsphincter pages 8-12, lang2019effectsofesophageal pages 18-23).
  • Interventions and outcomes: CP botulinum toxin injection rapidly restores belching and reduces symptoms in >85–95% short term; many retain function beyond drug window, suggesting reflex reprogramming; a subset needs repeat injection or myotomy (yousef2024upperesophagealsphincter pages 8-12, kahrilas2022retrogradeupperesophageal pages 4-6, krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

Phenotypic Manifestations (HPO)

  • Inability to belch (abelchia; cardinal feature) (kahrilas2022retrogradeupperesophageal pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).
  • Abdominal bloating (HP:0003270) (lechien2025etiologyclinicalpresentation pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Chest pain/discomfort (HP:0100749) (lechien2025etiologyclinicalpresentation pages 1-3).
  • Flatulence (HP:0032276) (lechien2025etiologyclinicalpresentation pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Nausea (HP:0002018) (lechien2025etiologyclinicalpresentation pages 1-3).
  • Hiccups (Singultus; HP:0025095) (kahrilas2022retrogradeupperesophageal pages 1-3).
  • Audible gurgling from chest/neck (symptom noted in series) (kahrilas2022retrogradeupperesophageal pages 4-6, kahrilas2022retrogradeupperesophageal pages 1-3).

Evidence items with PMIDs/DOIs, URLs, and dates

  • Kahrilas PJ. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility. Feb 2022. DOI:10.1111/nmo.14328; URL: https://doi.org/10.1111/nmo.14328 (Mechanism and HRIM provocation; therapeutic implications) (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Yousef A, et al. Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in R-CPD. Otolaryngology–Head & Neck Surgery. Apr 2024. DOI:10.1002/ohn.735; URL: https://doi.org/10.1002/ohn.735 (Case-control HRIM; elevated UES pressure/length; dysmotility) (yousef2024upperesophagealsphincter pages 8-12).
  • Dorfman L, et al. Pediatric R-CPD diagnosed by HRIM. Journal of Pediatric Gastroenterology and Nutrition. Mar 2024. DOI:10.1002/jpn3.12193; URL: https://doi.org/10.1002/jpn3.12193 (Selective retrograde UES failure; CP botulinum response) (xie2022casereporta pages 1-2).
  • Bastian RW, Smithson ML. Inability to Belch… Diagnosis and Treatment. OTO Open. Mar 2019. DOI:10.1177/2473974x19834553; URL: https://doi.org/10.1177/2473974x19834553 (Syndromic definition; BTX proof-of-concept) (kahrilas2022retrogradeupperesophageal pages 4-6).
  • Hoesli RC, Wingo ML, Bastian RW. Long-term Efficacy of Botulinum Toxin for R-CPD. OTO Open. Apr 2020. DOI:10.1177/2473974x20938342; URL: https://doi.org/10.1177/2473974x20938342 (Large outcomes series) (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Xie M, Wen H, Dou Z. Case report: Novel treatment for R-CPD. Frontiers in Neurology. Dec 2022. DOI:10.3389/fneur.2022.1005655; URL: https://doi.org/10.3389/fneur.2022.1005655 (HRM residual pressure normalized post-BTX) (xie2022casereporta pages 1-2).
  • Krekeler BN, Howell RJ. Cricopharyngeus muscle dysfunction: review. Eur Arch Otorhinolaryngol. May 2024. DOI:10.1007/s00405-024-08644-7; URL: https://doi.org/10.1007/s00405-024-08644-7 (Diagnostic considerations; HRPM-I thresholds; BTX) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Lang IM, Medda BK, Jadcherla S, Shaker R. Role of SLN in esophageal reflexes. Am J Physiol Gastrointest Liver Physiol. Jun 2012. DOI:10.1152/ajpgi.00007.2012; URL: https://doi.org/10.1152/ajpgi.00007.2012 (Belch subreflexes; SLN/vagal roles; CP inhibition) (lang2012theroleof pages 11-12, lang2012theroleof pages 1-1, lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Lang IM, Medda BK, Shaker R. Effects of esophageal acidification on UES reflexes. Am J Physiol Gastrointest Liver Physiol. Jan 2019. DOI:10.1152/ajpgi.00292.2018; URL: https://doi.org/10.1152/ajpgi.00292.2018 (EURR/EUCR modulation by acid; reflex plasticity) (lang2019effectsofesophageal pages 18-23).
  • Szczesniak MM. Esophageal afferents and reflexes (review). 2008 (vagal mechanoreceptors; GABA-B modulation of afferent drive and UES reflexes) (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94).

Gene/protein annotations with ontology terms

  • GABBR1 (HGNC:4085) and GABBR2 (HGNC:4086): GABA-B receptor subunits; process: modulation of vagal afferent neurotransmission controlling reflex UES relaxation (GO:0051932—GABAergic synaptic transmission; GO:0007216—G-protein coupled glutamate receptor signaling pathway as related family); evidence: GABA-B agonism blocks distension-induced UES responses (szczesniak2008…andpathophysiological pages 88-94).
  • Structural/functional units: intraganglionic laminar endings (IGLEs) of vagal afferents (cellular component: peripheral nervous system sensory ending; process: mechanosensory transduction; GO:0050974) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).

Cell type involvement (CL)

  • CL:0000187 skeletal muscle cell—cricopharyngeus fibers (effector of UES tone/relaxation) (kahrilas2022retrogradeupperesophageal pages 1-3).
  • CL:0000101 sensory neuron—vagal and SLN afferents mediating EURR/EUCR (lang2012theroleof pages 11-12, lang2012theroleof pages 6-7).

Anatomical locations (UBERON)

  • UBERON:0001041 upper esophageal sphincter; UBERON:0015205 cricopharyngeus muscle; UBERON:0001043 cervical esophagus; UBERON:0001738 larynx; UBERON:0001638 glottis (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 6-7, kahrilas2022retrogradeupperesophageal pages 1-3).

Chemical entities (CHEBI)

  • CHEBI:3603 botulinum toxin type A—therapeutic chemodenervation of CP (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).
  • CHEBI:2299 baclofen—GABA-B agonist modulating afferent signaling and UES reflex responses (szczesniak2008…andpathophysiological pages 88-94).

Biological process and cellular component mapping (GO)

  • GO:0003008 system process (reflex), GO:0006936 muscle contraction/relaxation, GO:0050954 sensory perception of mechanical stimulus, GO:0007610 behavior (belch reflex as patterned motor output), GO:0005886 plasma membrane (GABA-B receptors), GO:0045202 synapse (afferent modulation), GO:0045211 postsynaptic membrane (kahrilas2022retrogradeupperesophageal pages 3-4, szczesniak2008…andpathophysiological pages 88-94, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23).

Direct quotes supporting key statements

  • “Rapid esophageal distension reliably triggers belching… SLN transection blocked inhibition of cricopharyngeus EMG during the belch, whereas vagotomy abolished all belch-related responses.” (Am J Physiol Gastrointest Liver Physiol, 2012; https://doi.org/10.1152/ajpgi.00007.2012) (lang2012theroleof pages 6-7, lang2012theroleof pages 1-1).
  • “RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility.” (Otolaryngology–Head & Neck Surgery, 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
  • “All 51 patients achieved ability to belch and relief of associated symptoms… the majority seem to have ‘retrained’ the ability to belch on a potentially ‘permanent’ basis.” (OTO Open, 2019; https://doi.org/10.1177/2473974x19834553) (kahrilas2022retrogradeupperesophageal pages 4-6).

Summary for knowledge base

R-CPD is a reflex-specific neuromuscular disorder of the UES in which failure of cricopharyngeus relaxation during retrograde gaseous distension leads to air entrapment and cardinal symptoms. HRIM with provocation provides objective evidence; botulinum toxin to CP is a highly effective diagnostic-therapeutic intervention. Mechanistically, vagal and SLN afferents, mucosal vs muscular mechanoreceptors, and central medullary circuits coordinate belch subreflexes; afferent gating (e.g., GABA-B) and peripheral sensitization (acid) modulate reflex thresholds. Coexisting esophageal motility abnormalities and elevated UES basal pressure/length may influence phenotype and treatment durability (kahrilas2022retrogradeupperesophageal pages 1-3, yousef2024upperesophagealsphincter pages 8-12, kahrilas2022retrogradeupperesophageal pages 4-6, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23).

References

  1. (kahrilas2022retrogradeupperesophageal pages 1-3): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

  2. (kahrilas2022retrogradeupperesophageal pages 4-6): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

  3. (yousef2024upperesophagealsphincter pages 8-12): Andrew Yousef, Amanda Krause, Rena Yadlapati, Priya Sharma, and Philip A. Weissbrod. Upper esophageal sphincter and esophageal motility pathology on manometry in retrograde cricopharyngeal dysfunction. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 171:478-485, Apr 2024. URL: https://doi.org/10.1002/ohn.735, doi:10.1002/ohn.735. This article has 15 citations.

  4. (xie2022casereporta pages 1-2): Mengshu Xie, Hongmei Wen, and Zulin Dou. Case report: a case of novel treatment for retrograde cricopharyngeal dysfunction. Frontiers in Neurology, Dec 2022. URL: https://doi.org/10.3389/fneur.2022.1005655, doi:10.3389/fneur.2022.1005655. This article has 12 citations and is from a peer-reviewed journal.

  5. (krekeler2024cricopharyngeusmuscledysfunction pages 4-6): Brittany N. Krekeler and Rebecca J. Howell. Cricopharyngeus muscle dysfunction: a poorly defined disorder from diagnosis to treatment. European Archives of Oto-Rhino-Laryngology, 281:4519-4527, May 2024. URL: https://doi.org/10.1007/s00405-024-08644-7, doi:10.1007/s00405-024-08644-7. This article has 3 citations and is from a peer-reviewed journal.

  6. (kahrilas2022retrogradeupperesophageal pages 3-4): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

  7. (lechien2025etiologyclinicalpresentation pages 1-3): Jérôme R. Lechien, Marie Mailly, Stephane Hans, and Lee M. Akst. Etiology, clinical presentation, and management of retrograde cricopharyngeus dysfunction: a systematic review. Journal of Otolaryngology - Head & Neck Surgery, May 2025. URL: https://doi.org/10.1177/19160216251329012, doi:10.1177/19160216251329012. This article has 6 citations.

  8. (lang2012theroleof pages 11-12): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

  9. (lang2012theroleof pages 1-1): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

  10. (lang2019effectsofesophageal pages 18-23): Ivan M. Lang, Bidyut K. Medda, and Reza Shaker. Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter. American journal of physiology. Gastrointestinal and liver physiology, 316 1:G45-G54, Jan 2019. URL: https://doi.org/10.1152/ajpgi.00292.2018, doi:10.1152/ajpgi.00292.2018. This article has 19 citations.

  11. (szczesniak2008…andpathophysiological pages 58-61): MM Szczesniak. … and pathophysiological modulation of oesophageal afferent pathways: implications for oesophago-pharyngeal reflexes, regurgitation and symptom perception. Unknown journal, 2008.

  12. (szczesniak2008…andpathophysiological pages 88-94): MM Szczesniak. … and pathophysiological modulation of oesophageal afferent pathways: implications for oesophago-pharyngeal reflexes, regurgitation and symptom perception. Unknown journal, 2008.

  13. (lang2012theroleof pages 6-7): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

  14. (lang2012theroleof pages 9-10): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.